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1. Introduction 
In the last decades keeping reptiles as pets has been noticed to be more popular. 
Reptiles currently represent the second most common group of exotic animals 
found in the international pet trade after birds. Imports of a wide variety of reptile 
species to Europe has significantly increased. In 2005, the European Union (EU) 
was the top global importer of live reptiles for the pet trade; the European Union 
(EU) member states officially reported the import of 20,788,747 live reptiles 
between 2004 and 2014 (Auliya et al., 2016).  
On the other hand, numerous pathogenic viruses have recently been detected in 
reptiles, in particular in snakes, tortoises and lizards which are popular as pets all 
over the world. The international pet trade is capable of spreading infectious 
diseases across the world, and diagnostic tools need to be developed to screen 
captive and wild populations for exposure to pathogens. Thus, research focusing 
on viruses infecting reptiles has increased in recent years. Because there are no 
effective treatments available for viral infections in reptiles, euthanasia may be the 
last choice to prevent the spread of pathogens. This emphasizes the need for 
adequate methods to detect potential pathogens in infected and clinically healthy 
animals. Many viruses have been proven to be causative agents of disease in 
reptiles, however, the evidence for many as pathogens is relatively limited (Ariel, 
2011). Viruses can led to the loss of entire collections of susceptible animals, as 
has been described for paramyxoviruses in snakes and herpesviruses and 
ranaviruses in tortoises (Marschang et al., 1999, Essbauer and Ahne, 2001).  
Recently, new viruses have been detected and characterized in reptiles. These 
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new viruses are all potential pathogens, often associated with severe disease, and 
their characterization allows the development of new and powerful diagnostic tools 
for direct detection in infected animals. These viruses include new tortoise 
picornaviruses (TPV1) which have been grouped together in a new genus 
Torchivirus (previously virus “X”) (Zell et al., 2017). The virus has been often found 
in numerous tortoise species in Europe, mostly in terrestrial tortoise species 
(Marschang, 2011; Heuser et al., 2010). Another group of viruses that have been 
recently discovered in reptiles and that appear to be associated with an important 
disease complex are snake arenaviruses, which have been detected in boid 
snakes: annulated tree boas (Corallus annulatus) and boa constrictors (Boa 
constrictor) suffering from inclusion body disease (IBD) (Stenglein et al., 2012; 
Bodewes et al., 2013; Hetzel et al., 2013). Inclusion Body disease (IBD) is an 
infectious and serious fatal disease that affects captive boas and pythons. IBD is 
the most commonly diagnosed disease of suspected viral origin in these snakes. 
Previously the definitive diagnosis of IBD relied on histopathological evidence of 
inclusion bodies in post mortem tissues or biopsies, which are difficult to obtain 
safely in an already debilitated snake. Infected snakes with IBD often show 
neurological signs and infection often or always leads to death. The discovery of 
reptarenaviruses and their association with IBD was a big step to understand an 
important disease of constrictor snakes. Sunshinevirus was considered in this 
study as well. This virus was first detected in pythons in Australia. In 2008, an 
outbreak of neuro-respiratory disease occurred in a collection of Australian pythons 
in Southeast Queensland, Australia (Hyndman et al., 2012a). A new virus, most 
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closely related to the described paramyxoviruses, was detected in diseased 
snakes and has since been detected in additional python collections in Australia. 
(Hyndman et al., 2012b). Reptile sunshinevirus 1 is the type species of a new 
family Sunviridiae in the order Mononegavirales. Sunshineviruses are commonly 
found to cause neuro-respiratory and non-specific signs in pythons and they are 
often associated with a high mortality rate in infected snakes (Hyndman et al., 
2012b).  
The purpose of this study was to establish methods for the identification of three 
RNA viruses recently detected in reptiles: Picornaviruses  in tortoises, and 
arenaviruses and sunshinevirus in snakes, and to develop diagnostic reverse-
transcription polymerase chain reaction (RT-PCR) assays for their detection and 
identification in clinical samples as well as to partially characterize the detected 
viruses in order to optimize diagnostics and determine relationships between RNA 
viruses found in reptiles in Germany. 
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2. Literature review 
2.1 RNA viruses in reptiles 
The study of reptile virology is considered a relatively recent branch of virology. 
Most of the viruses which have been shown to be important pathogens in reptiles 
were discovered and described within the past few decades and there is still more 
to be studied and understood. RNA viruses in reptiles include retroviruses, 
reoviruses, rhabdoviruses, paramyxoviruses, arenaviruses, sunviruses, 
bunyaviruses, picornaviruses, caliciviruses, flaviviruses, and togaviruses. These 
have mostly been described in lizards, snakes and in chelonians (Table 2.1).  
 
Table 2.1 RNA viruses in reptiles (Marschang and Divers, 2014) 
virus family virus properties reptiles as host species 
Retroviruses 
(Retroviridae) 
ssRNA enveloped lizards, snakes, 
tuataras, chelonians, 
crocodilians 
Bornaviruses 
(Bornaviridae) 
ssRNA enveloped snakes 
Reoviruses 
(Reoviridae) 
dsRNA non-enveloped lizards, snakes, 
chelonians 
Rhabdoviruses 
(Rhabdoviridae) 
ssRNA enveloped lizards, snakes 
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Paramyxoviruses 
(Paramyxoviridae) 
ssRNA enveloped snakes, lizards, 
turtles 
Arenaviruses 
(Arenaviridae) 
ssRNA enveloped snakes 
Sunshineviruses 
(Sunviridae) 
ssRNA enveloped snakes 
Bunyaviruses 
(Bunyaviridae) 
ssRNA enveloped turtles, lizards 
Picornaviruses 
(Picornaviridae) 
ssRNA non-enveloped turtles, snakes, 
Caliciviruses 
(Caliciviridae) 
ssRNA non-enveloped snakes 
Flaviviruses 
(Flaviviridae) 
ssRNA enveloped turtles, snakes, 
cocodilians 
Togaviruses 
(Togaviridae) 
ssRNA enveloped turtles, snakes,  
lizards 
 
Research concerning reptile virology and associated diseases is important and 
interesting mainly because it helps to understand their importance for reptile health 
as well as virus taxonomy and evolution (Marschang, 2011). In addition, the 
characterization of these viruses allows the development of diagnostic methods, 
leading to better prophylaxis and prevention of the spread of infection and disease 
among these animals. This thesis deals with three different groups of RNA viruses, 
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all of which have been characterized within the past decade and all of which are 
associated with important diseases in reptiles: 
• Picornaviruses in tortoises 
• Arenaviruses in snakes 
• Sunshinevirus in pythons 
 
 
2.2 Picornaviruses 
2.2.1 General introduction to picornaviruses 
The term “picornavirus” was first coined around 1963 and applied to newly 
discovered small virus particles (Le Gall et al. 2008). All members of the family 
Picornaviridae show a similar structure and viral life cycle (Knowles et al, 2012). 
Morphologically, picornaviruses are non-enveloped about 22 to 30 nm in diameter 
with an icosahedral capsid surrounding the single-stranded RNA genome of 
positive polarity. The name “Pico” refers to the small size of the viral capsid, so 
"pico-rna-virus" literally means small RNA virus (Le Gall et al., 2008). The capsid 
shell has spherical structure and is composed of a densely-packed icosahedral 
arrangement of 60 copies of four non-identical virion polypeptide chains, VP1, 
VP2, VP3 and VP4 in icosahedral symmetry (Arnold et al, 1987, Smyth et al., 
1995). The fundamental capsid architecture is the same in all members (Smyth 
and Martin, 2002). The RNA carries a covalently bound non capsid viral protein 
(VPg) at its 5′ end and a polyadenylated tail at its 3′ end. The 3ˈ polyA tail also 
varies significantly in length between genera and has been shown to be required 
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for infectivity (Spector and Baltimore, 1974; Racaniello, 2007). The VPg is a small 
protein that acts as a primer for genome replication. The picornavirus genome 
consists of a single open reading frame translated as a single polyprotein. 
Nucleotide sequence analysis of many picornaviral RNAs has revealed a common 
organizational pattern. The genomes vary in length from 7,209 to 8,450 bases 
(Racaniello, 2007).  
 
2.2.2 Classification and replication  
The family Picornaviridae is divided into a number of genera which contain many 
important human and animal pathogens, including poliovirus, hepatitis A virus, 
foot-and-mouth disease virus, and rhinoviruses (Liljas et al., 2002). Classification is 
based on morphology, physicochemical and biologic properties, antigenic 
structures, genomic sequence and mode of replication.  According to the 
International Committee on Taxonomy of Viruses (ICTV), Picornaviridae belongs to 
the order Picornavirales and currently consist of 80 species grouped into 35 
genera as of March 2017 (Adams et al., 2017): Ampivirus, Aphthovirus, 
Aquamavirus, Avihepatovirus, Avisivirus, Cardiovirus, Cosavirus, Dicipivirus, 
Enterovirus, Erbovirus, Gallivirus, Harkavirus, Hepatovirus, Hunnivirus, Kobuvirus, 
Kunsagivirus, Limnipivirus, Megrivirus, Mischivirus, Mosavirus, Oscivirus, 
Parechovirus, Pasivirus, Passerivirus, Potamipivirus, Rabovirus, Rosavirus, 
Sakobuvirus, Salivirus, Sapelovirus, Senecavirus, Sicinivirus, Teschovirus, 
Torchivirus and Tremovirus, in addition to a number of unassigned picornaviruses 
(ICTV 2016). Viruses of the Picornaviridae family cause a wider range of illnesses 
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than most other virus families in humans, plants, insects and even algae (Ng et al., 
2015). Infection with various picornaviruses may be asymptomatic or may cause 
clinical syndromes such as aseptic meningitis (the most common acute viral 
disease of the CNS), encephalitis, the common cold, febrile rash illnesses (e.g. 
hand-foot-and-mouth disease), conjunctivitis, herpangina, myositis and 
myocarditis, and hepatitis. 
Picornaviruses multiply in the cytoplasm of the host cell, and their RNA acts as a 
messenger to synthesize viral macromolecules. Attachment of the virus to a 
specific cell surface receptor leads to structural changes in the capsid which allow 
the un-coating of the RNA genome and its subsequent entry into the cell.  The 
genome is first translated to provide copies of the viral proteins required for 
genome replication.  Replication is preceded by negative strand synthesis and this 
strand is then used as a template for positive strand RNA synthesis. Capsid 
proteins and newly synthesized viral genomes assemble into mature virions and 
are then released from the cell. The entire cycle is complete in around 5 to 10 
hours, with the exact duration depending on variables such as pH, temperature, 
cell type, and number of viral particles that infect the cell (Racaniello, 2007). 
 
2.2.3 Picornaviruses in tortoises  
Picorna-like-viruses have been frequently detected in a number of different 
terrestrial tortoise species in Europe, most commonly in spur-thighed tortoises 
(Testudo graeca) (Marschang, 2011). They have also been described in a wide 
range of other tortoise species in the family Testudinidae such as marginated 
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tortoises (T.marginata), Hermann’s tortoises (T.hermanni), Egyptian tortoises 
(T.kleinmanni) and leopard tortoises (Stigmochelys pardalis). They were long 
identified by isolation in cell culture (Heuser et al., 2014; Marschang, 2011). These 
viruses have been cultivated in Terrapene heart cells (TH-1; ATCC CCL-50), a 
chelonian cell line in which they cause cytolysis (Marschang, 2011). 
Characterization of these viruses was difficult and that is why they have been 
called virus “X” (Marschang and Ruemenapf, 2002).  
Heuser et al. published a study in 2014 which presented the detection of a picorna-
like virus (virus”X”) in young spur-thighed (Testudo graeca) and star tortoises 
(Geochelone elegans) suffering from a sudden softening of the shell. In other 
studies, virus “X” was detected in tortoises which have shown various disease 
signs including diphtheroid-necrotizing stomatitis, pharyngitis, rhinitis, pneumonia, 
enteritis, conjunctivitis, cachexia, sudden weight loss, and/or ascites (Marschang, 
2011). However, these viruses have also been isolated from healthy animals 
(Marschang and Ruemenapf, 2002). Tortoises infected with virus “X” in some 
cases have also been shown to be infected with other pathogens, especially 
herpesviruses and Mycoplasma spp (Marschang, 2011). Viruses were most 
frequently isolated from oral/ pharyngeal swabs in live animals, although they were 
also detected in conjunctival and cloacal swabs. These viruses have also been 
detected in a wide range of tissues including liver, kidney, heart, brain, and lung 
(Marschang, 1999). The virus isolated from the juvenile Hermann’s and leopard 
tortoises was named tortoise picornavirus 1 (TPV 1) (Heuser et al., 2014) and 
7077 nucleotides of its genome were sequenced. Analysis of the sequences 
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suggested that this virus has some similarities to the family Picornaviridae, but also 
diverges considerably from described picornaviruses. It was therefore proposed 
that this virus may represent a novel picornavirus genus (Heuser et al., 2010). The 
sequences from that study were not, however, made public. 
Recently, the near complete genome sequences of seven picornaviruses detected 
in tortoises were determined and analyzed (Farkas et al., 2015). These viruses 
were isolated from different captive tortoises (Testudo graeca, T.hermanni, Pyxis 
arachnoides and Centrochelys sulcata) in Europe. The genome organization of 
these strains showed a typical picornavirus layout and found to be homologous 
with the encoding region of other picornaviruses. The study suggested that these 
tortoise picornaviruses belong to a separate proposed genus in the family 
Picornaviridae, called “Topivirus” derived from tortoise picornavirus (GenBank 
accession numbers KM873611 to KM873617) (Farkas et al., 2015). This group of 
viruses has now been grouped in a new genus in the family Picornaviridae, named 
Torchivirus (from tortoise virus X (Greek chi)), with the typespecies Torchivirus A, 
isolated from a Hermann’s tortoise (GenBank accession number KM873611) (Zell 
et al., 2017). 
 Another tortoise PV was detected and identified in a Forsten’s tortoise 
(Indotestudo forstenii) and named tortoise Rafivirus A1 (GenBank accession No.: 
ToRaV-A, KJ415177). The complete genome of this new picornavirus was 
sequenced and the phylogenetic analysis demonstrates that tortoise rafivirus is 
only distantly related to the torchivirus and belongs to a proposed new genus 
„Rafivirus” (Ng et al., 2015).  
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2.2.4 Genome organization of picornaviruses  
The following scheme for the structure of the picornavirus genome was proposed 
based on the predicted protease cleavage sites, which is similar to the typical 
genome organization of many picornaviruses  
 
 
 
VPg+5'UTR[L/1A-1B-1C-1D-2Anpgp/2B-2C/3A-3BVPg-3Cpro-3Dpol]3'UTR-poly(A) 
Source: Knowels et al., 2012 
 
In the study by Farkas et al. (2015) nearly complete sequences were obtained from 
selected virus “X” isolates detected in terrestrial tortoises from Germany and 
Hungary between 2000 and 2013. The obtained genome sequences were 7065–
7079 nucleotides long (without the poly (A) tail). The sequence analyses of these 
tortoise picornaviruses showed disparate similarity of the amino acids of 
polyprotein sequences with members of other genera, mostly with Mosavirus, 
Cardiovirus, Cosavirus, and Senecavirus. The sequence of the polyprotein of 
Torchivirus was compared to that of its closest relative, murine mosavirus 
(accession number: JF973687). The complete capsid-protein-encoding P1 (784 
aa) and non-structural-protein-encoding P3 (767 aa) regions showed the highest 
identity (38.9 % and 34.7 %) to the Mouse Mosavirus A2, while the non-structural-
protein-encoding P2 (615 aa) region displayed restricted similarity to genet fecal 
theilovirus (26.2 %). The G+C content in the coding region was very low 
P1
P2
P3
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(approximately 35.8–36.8 %) in all strains. The G+C content was slightly higher in 
the capsid-protein-encoding P1 region (39.3 %) than in the non-structural-protein-
encoding P2 and P3 regions (36.1 and 36.2 %, respectively). The 3’ untranslated 
region UTR was 232 nucleotides long and extremely A+T rich (87%), (Knowels et 
al., 2012, Farkas et al., 2015). Additionally, a 65-nt-long part of the known un-
translated region 5´ UTR sequences was most closely related to canine kobuvirus 
1 and Aichi virus UTR sequences which belong to the genus Kobuvirus. The 3´ 
UTR did not show any similarities to sequences of picornaviruses in GenBank 
(Farkas et al., 2015). 
 
 
2.3 Arenaviruses 
2.3.1 General introduction to arenaviruses 
Arenavirus particles are spherical to pleomorphic and have an average diameter of 
50-300 nanometers, with the average diameter of spherical particles being 110-
130 nm (Charell and de Lamballerie X, 2003). Viruses in the family Arenaviridae 
have two segmented single-stranded RNA. All arenaviruses are enveloped in a 
dense lipid membrane covered with 8-10 nm long club-shaped projections. The 
name is derived from the Latin word "arenosus" meaning "sandy" which refers to 
the grainy appearance of virions when viewed in cross section, which represent 
ribosomes acquired from host cells. Arenaviruses are rapidly inactivated at 56°C, 
at pH below 5.5 or above 8.5, or by exposure to UV or gamma radiation. Genome 
replication occurs in the host cytoplasm and involves RNA-dependent RNA 
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synthesis. The first step is viral binding to the host cell membrane receptor through 
the viral GP glycoprotein, after which it is endocytosed into vesicles in the host cell. 
This is followed by fusion of the virus membrane with the vesicle membrane and 
release of the ribonucleocapsid into the cytoplasm. The next step is sequential 
transcription in which the viral mRNAs are capped in the cytoplasm. Consequently, 
replication starts when enough nucleoprotein is present to encapsidate 
neosynthetized genomes. The ribonucleocapsid interacts with the Z protein under 
the plasma membrane. Viral particles then bud from the surface of their hosts' cells 
(Buchmeier et al., 2007). 
 
2.3.2 Classification of family Arenaviridae 
Until recently, the family Arenaviridae contained a single genus, Arenavirus, 
members of which have a worldwide distribution and are known to infect 
rodents. According to the ICTV, 27 arenavirus species are currently 
recognized based on morphological, physiochemical, and serological 
parameters (Radoshitzky et al., 2015; 
www.ictvonline.org/virustaxonomy.asp?version=2014; Zapata and Salvato, 
2013; Coulibaly-N'Golo et al., 2011; Palacios et al., 2010). Ten of these 
viruses are associated with human diseases causing severe hemorrhagic 
fever (HF) and zoonotic diseases. Many arenaviruses are endemic among 
rodents and they are occasionally transmitted to humans (Salazar-Bravo et 
al, 2002). The first arenavirus isolated was lymphocytic choriomeningitis 
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virus (LCMV), a common human pathogen discovered in 1933 during the 
study of samples from a St. Louis encephalitis epidemic (Buchmeier et al., 
2007). Arenavirus infections have been detected in Africa, Europe, the U.S. 
and possibly some parts of Asia (Buchmeier et al., 2001).  Historically, two 
complexes were established within the arenavirus genus through the 
analysis of the serological and genetic relationships and their distribution in 
the world: The Old World Arenaviruses (OWAV) and the New World 
arenaviruses (NWAV), also known as the lassa-lymphocytic choriomeningitis 
virus (LASV-LCMV) complex and the Tacaribe complex (Bowen et al., 
1997). The geographical distribution of the different viral species is related to 
the natural host’s distribution and the specific diseases associated to each 
virus.  In addition, species classification is defined by significant differences 
of the viral protein sequence compared to other viruses in the genus (Zapata 
and Salvato, 2013). Recently, several studies have been published 
concerning the detection and isolation of a divergent group of arenaviruses 
in captive snakes, and based on phylogenetic analyses these reptilian 
arenaviruses constitute a sister group to mammalian arenaviruses. As a 
result, the previous single genus Arenavirus has been replaced by two 
genera, Mammarenavirus and Reptarenavirus, established to accommodate 
mammalian and reptilian arenaviruses, respectively, in the same family 
(Radoshitzky et al., 2015).  
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2.3.3 Genome organization of arenaviruses 
The arenavirus genome consists of two single-stranded RNA segments designated 
S (small) and L (large) encoding four viral proteins in a unique ambisense manner. 
The S segment contains two genes; the positive sense 5' portion which encodes 
the glycoprotein precursor (GPC) which is cleaved into envelope glycoproteins 
GP1 and GP2, and the negative sense 3' portion which encodes the nucleocapsid 
protein (NP). The L RNA segment contains two genes that encode two gene 
products, the viral polymerase (L protein) and the Z protein (Auperin et al, 1984, 
Buchmeier et al, 2001). GP1 and GP2 have an important role in viral entry in the 
host cell, uncoating and assembly. In addition, NP contributes to viral assembly, 
plays an important role in suppressing the innate immune response, and has 
exonuclease and nucleotide binding activity (Pinschewer et al., 2003; Qi et al., 
2010). The L segment (~7.2Kb) encodes the L protein that is an RNA-dependent 
RNA polymerase (RdRp) and encodes the small zinc-binding protein (Z) which is 
essential for viral transcription and replication (Zapata and Salvato, 2013). 
 
2.3.4 Inclusion body disease (IBD) in snakes: History, clinical 
signs and hosts 
One of the most important diseases infecting boid snakes in captivity is inclusion 
body disease (IBD). It has been recognized in the United States, Africa, Australia, 
and Europe. It was first described in the 1970s in the United States, where it 
affected captive neonate, juvenile and adult boid snakes in private and zoological 
collections and was associated with the eradication of entire boid collections 
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(Schumacher et al., 1994). At the time the disease was described, IBD was most 
commonly diagnosed in Burmese pythons (Python molurus bivittatus) and concern 
about this fatal disease rose in reptile veterinary medicine. IBD was then reported 
in captive native carpet pythons (Morelia spilota variegata) and diamond pythons 
(M. spilota spilota) in Australia (Carlisle-Nowak et al., 1998), in captive boa 
constrictors in the Canary Islands, Spain (Oros et al., 19981), and subsequently in 
Belgium (Vanncraeynes et al., 2006). The early 1990s witnessed cases of IBD 
which were diagnosed in boa constrictors more than pythons, but the cause of this 
epidemiologic shift is still unknown (Chang and Jacobson, 2010). IBD is 
characterized by the formation of intracytoplasmic inclusions found in numerous 
cells of different body organs (epithelial cells, visceral epithelial cells, and CNS 
neurons) (Jacobson et al., 2001). The inclusions are made up of a 68-KDa unique 
protein, which is now recognized as arenavirus nucleoprotein, also known as 
inclusion body disease protein (IBDP) (Wozniak et al., 2000; Hetzel et al., 2013). In 
boas, the disease course is variable. Animals either die within weeks or months or 
may have subclinical infection, thus it is possible that infections persist for long 
periods of time. In contrast, pythons generally develop severe fatal neurological 
signs within a few weeks. Although the most common clinical signs in boa 
constrictors are chronic regurgitation and CNS abnormalities characterized by 
stargazing, disequilibrium, tremors, and disorientation, stomatitis, pneumonia, and 
lymph proliferative disorders have also been reported in affected snakes 
(Schumacher et al., 1994). It is interesting to note that red and white blood cells 
develop the typical inclusion bodies and immunosuppression is believed to be a 
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key factor in disease development. Thus affected animals often die from secondary 
bacterial disease like salmonellosis, fungal (aspergillosis), and protozoal disease 
(amoebiasis) (Hetzel et al., 2013). 
IBD infects a wide range of boid and pythonid species from different families and 
has been described in Boa constrictors, green anaconda (Eunectes murinus), 
Haitian boa (Epicrates striatus), ringed tree boa (Corallus annulatus), garden tree 
boa (Corallus hortulanus), the Burmese python (Python molurus), reticulated 
python (Python reticulatus), ball python (Python regius) and Morelia spilota 
variegata and Morelia spilota spilota, which are known as Darwin carpet pythons 
(or carpet pythons) and diamond pythons. The prevalence of IBD in captive boid 
and pythonid collections is still unknown and so far there has been no report of IBD 
in indigenous wild populations. The question is therefore whether boas and /or 
pythons are the primary host of the IBD agent. Currently, the transmission routes 
of IBD remain unknown. It has been theorized that droplets in the air or 
contaminated feeding tools might be factors (Marschang and Divers, 2014); 
vertical transmission of IBD is also possible in ovoviviparous boids. Because snake 
mites (Ophionyssus natricis) have often been found in many snake collections 
experiencing IBD outbreaks, mites are thought to be a disease transmission factor 
(Chang and Jacobson, 2010). Currently no specific treatment is available; a 
quarantine period of 90 days and up to 6 months for boas has been suggested, 
coupled with mite control. Euthanasia is recommended for those individuals where 
there is a transmission risk or presenting with neurological signs. 
2.3.5 Arenaviruses in snakes 
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The etiology of IBD was long unknown, although a viral agent had long been 
suspected. A virus of the family Retroviridae was long suspected (Schumacher et 
al., 1994). Recent studies presented evidence of previously undescribed viruses 
with characteristics attributable to arenaviruses in boid snakes with IBD using a 
next generation sequencing (NGS) and bioinformatics approach (Stenglein et al., 
2012). The detected arenaviruses were found in six out of eight snakes diagnosed 
with IBD. These viruses have been named Golden Gate Virus (GGV) isolated from 
boa constrictors (Boa constrictor) and California Academy of Sciences Virus 
(CASV) identified in annulated tree boas (Corallus annulatus). Snake virus proteins 
which encoded in the S segment were related to the glycoproteins GP of filoviruses 
(e.g. Ebola and Marburg viruses), avian retroviruses (e.g., avian leukosis virus) 
and the cellular syncytin. In phylogenies, the snake virus proteins form an 
amonophyletic clade separate from those formed by the Old World and New World 
arenaviruses (Stenglein et al., 2012).  
Another group from the Netherlands identified arenaviruses in eight IBD positive 
snakes, seven boa constrictors and one emerald tree boa (Corallus caninus). The 
near completely sequenced arenavirus was named Boa Av NL B3. Phylogenetic 
analysis of the nucleotide (nt) of the nucleoprotein gene (NP) and L gene of Boa 
Av NL B3 virus revealed that the sequences were most closely related to the GGV 
nucleotides with pairwise sequence identities between 66.6 % and 80.9 % for all the 
ORFs (L, NP, Z, and GPC) and pairwise deduced amino acid identities between 
66.3 % and 90.8 %. The virus was more distantly related to CASV with pairwise 
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nucleotide sequence identities between 42.3 % and 60.0 % for all the ORFs and 
pairwise amino acid identities between 51.1 % and 58.4 % (Bodewes et al., 2013).  
An additional study from Europe reported one isolate, University of Helsinki virus 
(UHV-1) isolated from a boa constrictor with IBD. UHV-1 was completely 
characterized and represents an addition to the group known as boid inclusion 
body disease -associated arenaviruses (BIBDAVs). UHV was isolated from 
cultured cells of an IBD positive boa constrictor and sequenced by combining 
traditional and NGS techniques (Hetzel et al., 2013). Comparison of sequences of 
the major open reading frames of boa Av NL B3 with UHV-1 revealed that the 
pairwise identities of nucleoprotein (NP) was 77%, glycoprotein precursor (GPC) 
was 67%, RNA-depandent RNA polymerase (RdRp) was 89%, and RING domain-
containing zinc binding protein (Z) gene was 79% identical at the nucleotide level, 
likewise the pairwise identities of the genes respectively were 84%, 62%, 92%, and 
89% at the deduced amino acid level (Bodewes et al., 2014). To obtain more 
evidence of the etiology of IBD, cell lines were established from different tissues of 
IBD-positive and negative boa constrictors, inclusion bodies were characterized in 
the positive cells but none were observed in the negative cell culture and the virus 
has been successfully isolated from cell culture supernatant. Immunofluorescence, 
immunohistochemistry, and immunoblotting were performed. Polyclonal antibodies 
were produced against the nucleoprotein of snake arenavirus which recognized the 
BIBD inclusion bodies in tissue sections of infected snakes (Stenglein et al., 2012; 
Hetzel et al., 2013). In addition, reverse transcription-PCR (RT-PCR) was 
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established to reveal the presence of genetically diverse arenaviruses in snakes 
with IBD, confirming the causative role of arenaviruses (Hetzel et al., 2013).  
 
2.3.6 Diagnosis of arenaviruses and IBD in snakes 
Diagnosis of IBD is usually confirmed by microscopic observations of eosinophilic 
intracytoplasmic inclusion bodies found mainly in neurons of the central and 
peripheral nervous system and epithelial cells of major organs, as well as in 
haemopoietic and lymphatic tissues and both leukocytes and erythrocytes may 
contain intracytoplasmic inclusions (Schumacher et al., 1994; Marschang and 
Divers, 2014).  
Although the presence of these inclusions is a reliable indicator for IBD, their 
absence does not rule out an infection (Chang and Jacobson, 2010). Characteristic 
inclusion bodies have been found in affected internal tissues in dead animals 
including liver, kidney, stomach, spleen, respiratory and uro-genital tracts, 
pancreas and esophageal tonsils (Marschang and Divers, 2014). For diagnosis in 
live snakes, currently biopsies of oesophageal tonsils, gastric mucosa, liver, and 
kidney have been suggested (Jacobson et al., 1999). Direct blood smears can be 
useful for the detection of inclusions in blood cells, but may be less sensitive 
(Marschang and Divers, 2014). Since the identification of arenaviruses as the 
probable etiological agent of IBD, detection of arenaviruses has been performed 
through polymerase chain reaction (PCR) using samples from circulating blood 
cells, tissue biopsies and swabs (Hellebuyck et al, 2015; Hepojoki et al., 2015).  
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2.4 Sunshinevirus 
Sunshinevirus is a newly described virus that has been found in Australian 
pythons. It has been identified as a novel virus most closely related to viruses of 
the family Paramyxoviridae (Hyndman et al., 2012b) and recently been placed in a 
new family, Sunviridae in the order Mononegavirales (ICTV, 2016). Members of the 
order Mononegavirales are enveloped viruses, have linear, non-segmented single 
stranded negative-sense RNA genomes, and replicate by synthesizing complete 
anti-genome, and the virions bud off from the host cell, gaining their envelopes 
from the cellular membrane they bud from. The order currently includes eight virus 
families: Bornaviridae, Mymonaviridae, Filoviridae, Nyamiviridae, Paramyxoviridae, 
Pneumoviridae, Rhabdoviridae, and Sunviridae. The family Sunviridae includes a 
single genus (Sunshinevirus) with a single species (Reptile sunshinevirus 1) 
(Afonso et al., 2016). The family was established in 2016 to taxonomically 
accommodate Sunshine Coast virus (SunCV), previously referred to as "Sunshine 
virus" (Hyndman et al., 2012a). 
The first documented outbreak of sunshinevirus was in 2008 as neuro-respiratory 
disease spread in a collection of 70 Australian pythons in particular Antaresia sp., 
Morelia sp. and Aspidites sp. (Hyndman et al, 2012a). Histopathological 
examinations of the snakes that had died indicated the presence of a viral 
infection. The entire collection was euthanized and samples were used for virus 
isolation. A virus was isolated from the lung suspension of a black-headed python 
(Aspidites melanocephalus) and named BHP1-Lung. The genome of the isolate 
was obtained using NGS techniques and the analysis of the genome showed it to 
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be a novel virus. 17,187 nucleotides of the genome of sunshinevirus were 
assembled from RNA extracts from infected viper heart cells (VH2) displaying 
widespread cytopathic effects in the form of multinucleate giant cells. The viral 
sequence contains open reading frames (ORFs) identified as nucleocapsid (N), 
matrix (M), fusion (F) and polymerase (L) ORFs (Hyndman et al., 2012a).  The 
virus was named Sunshinevirus after the geographical origin on the Sunshine 
Coast of Queensland, Australia. 
Sunshinevirus has been found only in pythons including carpet python (Morelia 
spilota), diamond python (Morelia spilota spilota), black-headed python (Aspidites 
melanocephalus), woma python (Aspidites ramsayi), and spotted python 
(Antaresia maculosa), the virus has not been detected in other snake species and 
boas. However this host range is likely to expand as further testing is performed 
(Hyndman et al., 2014).  
 
2.4.1 Clinical signs and virus diagnosis 
Sunshinevirus has been found in pythons with a variety of clinical signs. Some 
infected animals displayed no overt signs of disease while for others the clinical 
signs were neurological, neurorespiratory or non-specific. Neurological signs 
included head tremors, opisthotonus, incoordination, diminished righting response, 
uncoordinated movement of the cranial and caudal body and erratic mouth gaping. 
Respiratory signs included a mild discharge of clear viscous fluid from the mouth 
and dyspnoea. Non-specific signs included anorexia, stomatitis, dermatitis, 
weakness, lethargy, regurgitation, inappetence and weight loss (Hyndman et al., 
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2012b). However, several sunshinevirus positive snakes appeared healthy and 
showed no clinical signs of disease; infection in the snakes was confirmed by PCR 
(Hyndman et al., 2014). 
Diagnosis of sunshinevirus has been performed usually by PCR in both oral and 
cloacal swabs, fresh samples of brain, lung, liver and kidney, and formalin-fixed 
paraffin-embedded tissues (Hyndman et al., 2012b). Thus, it is assumed that the 
virus could be taken up via the oral cavity or the trachea-lung and possible routes 
of transmission would be fecal-oral, air-borne, droplet, or direct contact. 
Sunshinevirus was most frequently detected in the brain in infected snakes, and 
most of the pathology in diseased snakes is seen in the hindbrain (Hyndman et al., 
2014). Sunshine virus has also been detected in blood by PCR (Hyndman 
unpublished data); this result has raised the prospect of blood-sucking 
ectoparasites (e.g. mites) as transmission factors of sunshinevirus between snakes 
(Hyndman et al., 2014). The presence of sunshinevirus in snakes was also 
confirmed by microscopic examination and virus isolation on VH2 cell cultures 
(Hyndman et al, 2012 a). 
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3. Aims of the study 
Based on the description of a number of new RNA viruses infecting reptiles and 
their apparent clinical relevance in reptile medicine, the aim of this study was to 
generally improve and test molecular diagnostic tools for the detection of 
several newly described reptile viruses in clinical samples in a diagnostic 
laboratory. Specifically, the aims were: 
 
1. To establish a molecular diagnostic test for the detection of tortoise 
picornavirus (Torchivirus) in diagnostic samples for use on historical virus 
isolates as well as clinical samples, and to characterize the detected viruses 
by partial sequencing. 
2. To gain sequences and deduced phylogenetic information about 
picornaviruses occurring in tortoises. 
3. To screen RNA from clinical samples from boas and pythons for the 
presence of reptarenaviruses using an RT-PCR with primers described by 
Stenglein et al. (2012), and to characterize the detected viruses by partial 
sequencing. 
4. To identify sunshinevirus in snake samples from captive pythons in Europe 
using the RT-PCR method described by Hyndman et al. (2012). 
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4. Materials and methods: 
 
4.1 Laboratory equipments and utensils 
for processing diagnostic samples 
Branson-250 Sonifier    Ausrüstung 707,  
    Schwäbisch Gmünd 
Varifuge 3.2 RS, Centrifuge  Heraeus Osterode   
BD FalconTM 15 ml polypropylene  Biosciences Discovery Lab ware,  
Conical tubes   Heidelberg   
 
for cell culture and virus isolation 
Biosafety sterile cabinet, Heraeus  Kendro Laboratory Products, Hanau. 
Sterile Laminar flow cabinet  Prettl, Bempflingen 
Fireboy S1000, bunsen burner   Tecnorama, Fernwald 
CO2 Incubator     Binder Tuttlingen 
Inverted light microscope    Leitz, Wetzlar 
30mm diameter Cellstar®    Greiner Bio-One GmbH, Frickenhausen 
BD Falcon BD Falcon™ with  Becton Dickinson GmbH, Heidelberg 
vented cap (75 cm3) 
 
for the extraction of viral RNA/ RT-PCR 
Table centrifuge: 
Centrifuge 5415 R      Eppendorf, Wesseling Berzdorf 
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Centrifuge 5415 D    Eppendorf, Wesseling Berzdorf 
Vortex Genie 2™     Bender & Hohlbein AG, Zurich (CH) 
Dry Bath incubator     Kisker, Steinfurt 
(Heating block) 
Thermal cyclers: 
Peqlab Primus 35 Adv.   Peqlab, Erlangen 
Doppio thermocycler   VWR, Darmstadt 
Mastercycler Gradient   Eppendorf, Wesseling Berzdorf 
Pipettes 1-10 µl, 10-100 µl   Biozyme scientific GmbH, Oldendorf 
 and 20-200 µl  
 0.5 ml PCR tubes     Biozyme scientific GmbH, Oldendorf 
1.5 ml reaction tubes   Eppendorf, Hamburg. 
 
for gel electrophoresis/ gel extraction 
Sterile surgical blades   Aesculap Ag, Tuttlinge 
Power supply:  
Consort 443 electrophoresis   Keutz, Reiskirchen 
EC-105 electrophoresis    Biometra, Gottingen 
Agagel Mini G45/2- gel chamber  Biometra, Gottingen 
UV-transilluminator, Infinity 1000 Vilber  Lourmat,Eberhardzell 
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4.2 Cell lines used in experimental trials  
Terrapene heart cells, TH1: established from the heart of the box turtle Terrapene 
carolina. Obtained from American Type Culture Collection Rockville, MD, ATCC-
CCL 50 
Viper heart cells, VH2: established from the heart of a female Russells Viper 
Vipera russelli. Obtained from American Type Culture Collection USA, ATCC CCL-
140. 
 
4.3 Chemicals, reagents and solutions  
4.3.1 Cell culture and virus isolation  
Water, deionised and filtered: 
Milli-Q® water (Millipore GmbH, Eschborn)  
 
Dulbecco´s modified Eagle medium (DMEM)  
13.4 g/L DMEM medium, 4.5 g/L D-glucose, with L-glutamine, were all dissolved in 
1 L Milli-Q® water. 2.2 g/L NaHCO3 (Merck KGaA, Darmstadt) was added and the 
solution was stirred thoroughly until the ingredients were dissolved completely. 
After that, the medium was sterile filtered and kept at 4°C for future use.  
 
Amphotericin B  
The lyophilized Amphotericin B (Biochrom AG, Berlin, Germany) was suspended in 
5 ml Milli-Q® water. The final concentration of the stock solution was about 
250µg/ml. 
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Gentamicin sulfate solution  
640 U/mg Gentamicin sulfate (Biochrom AG, Berlin, Germany) dissolved in Milli-Q® 
water to achieve a concentration of approx. 3200 U/ml in the stock solution.  
 
Penicillin-G solution  
Penicillin-G (1664 U/mg) (Biochrom AG, Berlin, Germany) was dissolved in Milli-Q® 
water to achieve a concentration of about 100000 U/ml in the stock solution.  
 
Streptomycin sulfate solution  
Streptomycin sulfate (758 U/mg) (Biochrom AG, Berlin, Germany) was dissolved in 
Milli-Q® water to achieve a concentration of about 190000U/ml in the stock 
solution.   
 
FBS  
Fetal bovine serum (FBS) (Biochrom AG, Berlin, Germany)  
 
NEA 
Non essential amino acids (Biochrom AG, Berlin, Germany)   
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Growth medium: Dulbecco´s modified Eagle medium (DMEM) for cell culture 
and virus isolation contains the following substances in ml /500 ml DMEM 
          Final concentration 
50 ml   10% (v/v) FBS 
5 ml     1% (v/v) NEA 
2 ml     200 U/ml Penicillin-G-solution     
2 ml     6.4 U/ml Gentamycin sulfate-solution    
2 ml     380 U/ml  Streptomycin sulfate-solution   
4 ml     0.5 μg/ml Amphotericin B-solution     
 
Trypsin-versen (TV) solution 0.05 %  
0.20 g/L   3 mM  KCl (Merck KgaA, Darmstadt)  
0.20 g/L  1 mM  KH2PO4 (Merck KgaA, Darmstadt)  
2.31 g/L  6 mM  Na2HPO4x12 H2O (Merck KgaA, Darmstadt)  
0.132 g/L 0.9 mM CaCl2 x 2 H2O (Merck KgaA, Darmstadt)  
8.00 g/L  136 mM  NaCl (Merck KGaA, Darmstad)  
0.5 g/L  1:250  Trypsin-dry substance (Biochrom AG, Berlin)  
1.25 g/L  3 mM   U/mg Versen (Titriplex III) (Merck KgaA, Darmstadt)  
0.05 g/L  37900 U/L  Streptomycin sulfate (Biochrom AG, Berlin)  
0.06 g/L 100000 U/L  Penicillin-G (Biochrom AG, Berlin)  
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DMEM supplemented with 2x antibiotic concentration: amount added to 500 
ml (2x AB DMEM) used for processing diagnostic samples 
 Final concentration 
4 ml  400 U/ml Penicillin-G-solution  
4 ml  12.8 U/ml Gentamycin sulfate-solution  
4 ml  760 U/ml Streptomycin sulfate solution 
8 ml  1 μg/ml Amphotericin B-solution  
 
4.3.2 Viral RNA extraction 
Diethylpyrocarbonate (DEPC) as nuclease free water   
10 ml DEPC (Fluka, Buchs SG, Switzerland) was dissolved in 90 ml of absolute 
ethanol to reach a concentration of 10% of the DEPC stock solution. This solution 
was placed in brown bottles and kept in the dark. A 1% working solution was made 
by mixing 1ml of the stock solution in 99 ml sterile Milli-Q® water. The mixture was 
then autoclaved at 120 °C for 30 min and stored at 4 °C until use. 
Silica-matrix  
60 g of Silicon dioxide (SiO2) (Sigma-Aldrich Chemie GmbH, Steinheim, Germany) 
was added to a measuring cylinder and filled with DEPC water up to 500 ml and 
mixed thoroughly. The cylinder was placed at room temperature for 24 hours to 
allow good sedimentation. Using a pipette, 430 ml of the supernatant were 
removed and discarded. The cylinder was again filled with DEPC water up to 500 
ml to re-suspend the sedimented Silica particles. Following an additional 
sedimentation of 5 hours, 440 ml of the supernatant was discarded. The pH of the 
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solution was adjusted to 2.00 by the addition of 600 µl of 25 % HCl (6.85 M). The 
solution was shaken to re-suspend the silica, and then aliquoted into 1.5 ml 
nuclease free tubes in 1 ml portions, autoclaved at 121 °C for 15 min and kept at 
room temperature in the dark. 
Tris-HCl  
12.1 g Tris-HCl (Carl Roth GmbH & Co, Karlsruhe, Germany) was dissolved in 1L 
Milli-Q® water and the pH of the solution was adjusted to 6.40 with 0.01 M HCl. 
The solution was stored at 4 °C. The final concentration of Tris- HCl solution was 
0.1 M   
Ethylenediamine-tetraaceticacid (EDTA)   
7.44 g EDTA (Carl Roth GmbH & Co, Karlsruhe, Germany) was dissolved in 100 
ml DEPC water to reach a final concentration of about 0.2 M. With 5 N NaOH, the 
pH of the solution was adjusted to 8.00. The solution was then autoclaved at 120 
°C for 30 min and stored at 4 °C until use. 
Lysis buffer (LB)  
1 ml Triton X-100 (Sigma-Aldrich Chemie GmbH, Steinheim, Germany), 48 g 
Guanidinethiocyanate (Carl Roth GmbH & Co, Karlsruhe, Germany), 8.8 ml of 0.2 
M EDTA (pH 8.0) and 40 ml 0.1 M Tris HCl (pH 6.40) were mixed together in a 250 
ml glass beaker. The beaker was wrapped in aluminum foil and placed in a water 
bath (56 °C, 15 min) to dissolve the ingredients. The solution was then stored in 
the dark at room temperature for future use.  
Washing buffer (WB)  
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48 g Guanidinethiocyanate and 40 ml 0.1 Tris HCl (pH 6.40) were mixed in a 250 
ml glass beaker. The beaker was wrapped with aluminum foil and placed in a 
water bath (56 °C, 15 min) to dissolve the contents. The solution was stored in the 
dark at room temperature until use.  
70 % Ethanol  
35 ml of absolute Ethanol Rotipuran® 99.8 % (Carl Roth GmbH & Co, Karlsruhe, 
Germany) and 15 ml Milli-Q® water were mixed in a nuclease free 50 ml tube. The 
tubes were then kept at room temperature. 
RNase inhibitor  
RiboLockTM RNase Inhibitor 40 U/µl (Fermentas GmbH, St. Leon-Rot, Germany) 
was kept frozen at – 20 ºC until use.  
Acetone  
Acetone Rotipuran® 99.8 % (Carl Roth GmbH & Co, Karlsruhe, Germany) was 
kept in nuclease free 50 ml plastic tubes and stored at room temperature. 
Nuclease-free water   
(QIAGEN Hilden, Germany) 
 
4.3.3 Reverse transcription polymerase chain reaction (RT-PCR) 
All chemicals and reagents used for RT-PCR were obtained from Fermentas, St. 
Leon-Roth and Genaxxon bioscience GmbH, Ulm 
10x Taq buffer (with KCl) 
10x buffer E with (NH4)2SO4 
25 mM MgCl2 
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40 U/μl  RiboLock™ RNase Inhibitor   
200 U/μl  RevertAid™ Reverse Transcriptase RT-Enzyme 
5 U/μl  Taq DNA Polymerase 
5x transcriptor reaction buffer (250 mM Tris/HCl, 150 mM KCl, 40 mM MgCl2) 
1 mM DTT (Dithiothreitol) 
  
Primers  
Primers were ordered from biomers.net (Ulm, Germany). The lyophilized primer 
was first centrifuged at maximum speed for 10 seconds to be settled as sediment 
in the bottom of the tube, then a stock solution (100 pmol/μl) was prepared by 
dissolving the primer with the appropriate amount of Milli-Q® water (calculated by 
the provider) into 1.5 ml RNase- free centrifuge tubes. The tube was then vortexed 
for five seconds and allowed to stand on ice for 15 min. Subsequently, the tube 
was again shortly vortexed to ensure the proper mixing of the primer components 
then was stored at -20°C until use. The stock solution was diluted in Milli-Q® water 
to achieve working solutions of 10 pmol/μl and 50 pmol/μl.  
 
dNTPs 2´- desoxynucleosid-5´-triphosphat dATP, dCTP, dGTP, and dTTP 
(100 mM, Fermentas,St. Leon-Rot)  
A working solution (2 mM) was prepared from the stock solution (100 mM) by 
adding 40 μl of each nucleotide of the stock solution to 1840 μl Milli-Q® water. After 
mixing well, the solution was aliquoted and stored at -20° C until use. The final 
concentration of each dNTP in the master mix was 0.2 mM. 
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4.3.4 Gel electrophoresis  
1x TAE-buffer (Roth, Karlsruhe,Germany)   
The stock solution of 50x TAE buffer consisted of 242 g Tris, 57.1 ml acetic acid 
and 100 ml 0.5 M EDTA, maintained at pH 8.00. To prepare 1x working solution, 
40 ml 50x TAE buffer were diluted with 1960 ml Milli-Q® water.   
  
Ethidium bromide solution (Roth, Karlsruhe,Germany)    
The working solution was prepared by dissolving 10 mg ethidium bromide in 10 ml 
aqua dest under the laminar flow cabinet. This solution was stored in the dark and 
handled carefully using nitrile gloves. 
Agarose Roth (Karlsruhe)/Germany  
6x Loading Dye  Fermentas (St. Leon-Roth),Germany  
GeneRuler™100 bp DNA Ladder Fermentas (St. Leon-Roth),Germany 
GeneRuler™ DNA Ladder Mix  Fermentas (St. Leon-Roth),Germany 
 
4.3.5 Gel extraction  
PeqGOLD Gel-Extraction Kit (PEQLAB, Erlangen). Detailed protocol: see methods 
4.9. 
 
4.4 Samples and isolates: 
4.4.1 Samples for picornavirus studies 
A total of 37 virus isolates from TH1 cell culture were investigated for the presence 
of picornaviruses using RT-PCR techniques. The isolates were collected between 
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1997 and 2012 under the supervision of PD Dr. Rachel Marscahng. In addition, 
screening was performed on 75 clinical samples from a total of 51 different 
tortoises collected between 2012 and 2013 (Table 11.2 in appendix). The samples 
were obtained from different tortoises and oral/ cloacal and conjunctival swabs, 
mostly from private collections from Germany, the United Kingdom, Italy, and 
Switzerland.  
 
Table 4.1 Picornavirus isolates  
Virus isolates provided by PD Dr. Marschang 
 
Lab No.   Isolates Host species 
1.  TGT1a/96 Spur-thighed tortoise  
Testudo graeca 
2.  374/96 unknown 
3.  33/97 Spur-thighed tortoise  
Testudo graeca 
4.  2442/97 TGT8 Spur-thighed tortoise  
Testudo graeca 
5.  907/97 
TGT10 
Spur-thighed tortoise  
Testudo graeca 
6.  2443/97 Spur-thighed tortoise  
Testudo.graeca 
7.  2445/97 Egyptian tortoise  
Testudo kleinmanni 
8.  1791/98 Spur-thighed tortoise  
Testudo graeca 
9.  2281/7/98 Testudo spp. 
10.  2691/98 Leopard tortoise  
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Stigmochelys pardalis 
11.  1167/5/99 Tortoise 
12.  1167/9/99 Tortoise 
13.  659/00 Hermann’s tortoise  
Testudo hermanni 
14.  2041/00 Russian tortoise  
Testudo horsfieldii 
15.  5_03 Spider tortoise 
 Pyxis arachnoids 
16.  16_03 Testudo sp. 
17.  26_03 Marginated tortoise  
Testudo marginata 
18.  31_03 Hermann’s tortoise  
Testudo hermanni 
19.  2_4_04 Tortoise 
20.  5_04 Spur-thighed tortoise 
 Testudo graeca 
21.  14_04 Hermann’s tortoise  
Testudo hermanni 
22.  15_04 Spur-thighed tortoise 
 Testudo graeca 
23.  16_04 Hermann’s tortoise  
Testudo hermanni boettgeri 
24.  17_04 Hermann’s tortoise  
Testudo hermanni boettgeri 
25.  19_1_04 Hermann’s tortoise  
Testudo hermanni 
26.  19_2_04 Hermann’s tortoise  
Testudo hermanni 
27.  9_05 African spurred tortoise  
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Centrochelys sulcata 
28.  25_09 Marginated tortoise 
 Testudo marginata 
29.  19_10 Russian tortoise 
 Testudo horsfieldii 
30.  124_1_10 Spur-thighed tortoise  
Testudo graeca 
31.  124_2_10 Spur-thighed tortoise  
Testudo graeca 
32.  124_4-10 Spur-thighed tortoise  
Testudo graeca 
33.  124_5_10 Spur-thighed tortoise 
 Testudo graeca 
34.  124_6_10 Spur-thighed tortoise  
Testudo graeca 
35.  124_7_10 Spur-thighed tortoise  
Testudo graeca 
36.  36_10 Marginated tortoise  
Testudo marginata 
37.  144_10 Spur-thighed tortoise  
Testudo graeca 
 
 
4.4.2 Samples for arenavirus studies 
In order to obtain a positive control for the proposed diagnostic RT-PCR, RNA from 
four organ samples: lung, liver, kidney and intestine from a boa constrictor with 
histologically diagnosed IBD were tested with RT-PCR (4.7.2). All four samples 
resulted in strong PCR signals at 300 bp. Sequence analyses revealed 97% 
similarity to the recently described snake arenavirus: Golden Gate Virus 
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Alethinophid 1 reptarenavirus, (Genbank accession number: NC_018483). These 
four samples were used as positive controls during the screening process.  Over a 
period of nine months (2012 - 2013), 450 different diagnostic samples (swabs, 
tracheal-lung lavage, serum and whole blood, fresh and paraffin embedded 
tissues) were screened for the detection of arenaviral RNA using RT-PCR and 
sequence analysis. These samples were drawn from 170 snakes (boid, pythonid). 
From dead snakes, organ samples (brain, kidney, spleen, gut, skin, lung, liver, 
testis and pancreas) were sent to be tested. The samples tested came from 
various species and included animals that tested IBD positive on histology or 
cytology as well as snakes that appeared to be IBD negative. The animals and 
samples tested are shown in Table 11.4 in the appendix. 
 
4.4.3 Samples for sunshinevirus studies 
Two cell culture isolates (PMV P8 and PMV P10) of sunshinevirus were kindly 
provided by Dr. Tim Hyndman, Murdoch University, Perth, Australia, as positive 
controls for developing an RT-PCR for the detection of sunshinevirus. Both viruses 
had been isolated on VH2 cells. For the presence of sunshinevirus, screening was 
performed for a total of 38 different samples including tissues (brain, lung, kidney, 
skin, liver, and pancreas), and lung lavages from 12 snakes (Table 5.2). 
 
4.4.4 Processing of diagnostic samples: 
Swabs, blood, and organ samples of examined animals were placed in 15 ml 
tubes, immersed in 3 ml growth medium DMEM supplemented with 2x 
concentration of antibiotics (4.3.1) and sonicated at an output level of 30 for 3 
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impulses for the destruction of cell membranes. Subsequently, samples were 
centrifuged at 3000xg for 15 min for removal of bacteria and cell debris and then 
stored at 4 ºC. 
 
4.5 Subculture and preparation of tissue culture dishes for virus 
isolation:  
After discarding the DMEM from a complete cell monolayer flask (75 cm3) and 
washing with 5 ml trypsin, the cells were incubated with 1 ml trypsin at room 
temperature for a few minutes. Subsequently, the flask was shaken by hand until 
the cells were detached. 4 ml of growth medium was added to the subcultured 
cells. A glass pipette was used to separate the cells by pipetting them up and down 
several times. The cells were diluted at a ratio of 1:10, 1:5, or 1:2 during 
subcultivation (depending on the density of the cells) by transferring 0.5, 1, or 2.5 
ml of the cell suspension respectively into 17 ml DMEM. To prepare tissue culture 
dishes the cell suspension was mixed 1:10 with DMEM in a cell reservoir to 
prepare 30 mm tissue culture dishes. 2 ml of this diluted suspension was added to 
each dish. One day old dishes were used for virus isolation. All flasks and dishes 
were incubated at 28 °C with 5 % CO2. 
 
4.5.1 Virus isolation 
Virus isolation was attempted from samples or isolates on Russell’s viper heart 
cells (VH-2, ATCC: CCL-140) and/or Terrapene heart cells (TH-1, ATCC: CCL-50) 
depending on the origin of the sample from snakes or tortoises. 200 µl of the 
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sample supernatant were inoculated onto one day old, medium-free tissue culture 
dishes, with about 70% confluent cell monolayers. Dishes were then incubated for 
2 hours at 28 ºC with 5% CO2. After incubation, 2 ml DMEM supplemented with 
2% FBS, 1% NEA and antibiotics (see 4.3.1) were added to each dish. One dish 
was always left un-inoculated as a cell control. Inoculated cells were examined for 
cytopathic effects (CPE) approximately every 2-3 days with an inverted light 
microscope (Wilovet, Wetzlar, Germany), and dishes were frozen when extensive 
CPE was seen.  
 
 
4.6 Extraction of viral RNA  
RNA – Preparation modified from Boom et al. (1990)  
1. 300 µl of the cell culture supernatant or of the homogenous supernatant after 
processing the diagnostic samples (see 4.4.4), was mixed with 900 µl lysis buffer 
and 40 µl silica matrix in 2 ml tubes. The suspension was then incubated at room 
temperature for 10 minutes and vortexed every 3 minutes.  
2. The suspension was centrifuged with Varifuge 3.2 RS, 14000 rpm at 4°C for 1 
minute and the supernatant was discarded.   
3. The pellet was washed with 1000 µl washing buffer twice then was washed with 
1000 µl 70% ethanol twice respectively. After each washing step, the pellet was 
vortexed, centrifuged with Varifuge 3.2 RS, 14000 rpm at 4°C for 0.5 minute and 
the supernatant was discarded.  
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4. The pellet was washed a final time with 1000 µl acetone, followed by 
centrifugation with Varifuge 3.2 RS, 14000 rpm at 4°C for 3 minutes. The acetone 
was then decanted and the pellet dried (10 min. 56 °C) on a heating block.  
5. Following complete drying, 60 µl of nuclease-free water and 1 μl RNase-inhibitor 
were added to the pellet, vortexed and incubated at 56°C for 15 minutes. During 
that the tubes were vortexed every 5 minutes. After incubation the suspension was 
centrifuged with the Varifuge 3.2 RS, 14000 rpm at 4°C for 3 min. 
6. The supernatant was carefully removed with a micropipette (without any contact 
to the silica matrix) and transferred to a new 0.5 ml tube. This process was 
repeated once again for a total of approximately 100 μl of prepared RNA 
suspension and the supernatant stored immediately at -80 °C. 
 
 
4.7 Reverse transcription – polymerase chain reaction 
4.7.1 RT-PCR protocol used to identify picronaviruses from the isolates:  
The reaction was performed in two rounds (Table 4.3). 2 µl of the prepared viral 
RNA was added to a 9.4µl mixture containing the reverse primer then incubated at 
95°C for 5 min and immediately transferred to liquid nitrogen and placed on ice to 
thaw. In the meantime, a master mix was prepared. 8.6 µl from this mix was 
transferred to the first reaction tube for a final volume of 20 µl. The reaction mixture 
was then incubated 30 min at 50°C, 5 min at 85°C and stored at 4°C. In this step 
reverse transcription was carried out. For the amplification step, 2.5 µl of the first 
round RT-PCR product was added to a 47.5 µl reaction mixture (Table 4.3). The 
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mixtures were amplified with an initial denaturation at 95°C for 2 min followed by 
40 cycles at 95ºC for 20 s, 45ºC for 20 s and 70ºC for 20 s. The extension time at 
70°C was 1 min followed by hold step at 4°C. 
 
4.7.1.1 Primers: 
Table 4.2 Description of the primer sets used in the RT-PCR for the detection of 
picornavirus virus in tortoise. 
 
sets Primers Expected size Source of the 
sequences 
1 Oligo dT18 TTTTTTTTTTTTTTTTT 900 bp Dr. Günther Keil, FLI 
Riems, personal 
communication 
Kei+4343 CTTCAGTATAGAAAACGGATTTG
ATG 
2 RKei2 AAGCCAATCCTGCAACACT 400 bp New primers designed 
for RT-PCR 
amplification 
FKei2 CTACCATCAGGATGCAGTT 
3 RVX1 TGCACATGGCGGTTCCAGTG 1120bp 
FVX1 GCCATGGCACCCCTCCTTCT 
4 RVX3 GATGCATTCATTTGAACTT 600-800 bp 
FVX3 TTTCATCTAGTGCTGATGCT 
5 Rtgt1 TGCCATTTACTGCTCTTGGA 238bp 
Ftgt1 TGACCAGTGGGTTCTACAACTTC 
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Table 4.3 Chemicals and reagents used in the RT-PCR for the detection of picornavirus in tortoise  
 
Reagent 1st round RT-
PCR 
Final 
concentration 
Reagent 2nd round RT-
PCR 
Final 
concentration 
 volume in 20 µl 
total amount 
  volume in 50 µl 
total amount 
 
Millipore water 8.4 µl  Millipore water 32.25 µl  
50 mM Reverse 
primer 
1 µl 2.5 mM 10x buffer + 
(NH4)2SO4 
5 µl 1x 
Template 2 µl of extracted 
viral RNA 
sample 
 Template 2.5 µl of the 1st 
round RT-PCR 
products 
 
5x Transcriptor 
reaction buffer 
4 µl 1x 25 mM MgCl2 
 
3 µl 1.5 mM 
2 mM dNTPs 2µl 0.2 mM 2 mM dNTPs 5 µl 0.2 mM 
40 U/μl Ribolock 
RNase inhibitor 
0.5 µl 1 U/μl 50 mM forward 
primer 
0.625 µl 0.625 mM 
1 mM DTT 
(Dithiothreitol) 
1 µl 0.05 mM 50 mM reverse 
primer 
0.625 µl 0.625 mM 
200 U/μl RT (reverse 
transcriptase) 
1.1 µl 11 U/μl 5 U/μl Taq DNA-
polymerase 
1 µl 0.1 U/μl 
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4.7.2 RT-PCR protocol used for the detection of Arenaviruses: 
The primer combinations MDS-400 (5’-TTCATTTCTTCATGRACTTTRTCAATC-3’) 
and MDS-402 (5’-GGSATAACAAAYTCACTTCAAATATC-3’) targeting part of the 
glycoprotein gene (expected size 300 bp) (Stenglein et al., 2012) were used for 
reptarenavirus screening.  
 25 µl of master mix was prepared with the necessary reagents for the RT-PC 
reaction (Table 4.4). After the RT reaction at 42°C for 60 min, amplification was 
carried out with an initial denaturation at 95°C for 2 min, followed by 30 cycles with 
cycling conditions: 94°C for 30 s, 45°C for 30 s, and 72°C for 1 min. There was a 
final extension at 72°C for 5 min followed by cooling at 4°C until further processing 
on gel.  
 
Table 4.4 Chemicals and reagents used in the RT-PCR for the detection of 
reptarenavirus  
 
Reagent One round RT-PCR Final concentration 
 volume in 25 µl total 
amount 
 
Millipore water 9.25 µL  
10x buffer + KCL 2.5 µL 1x 
2 mM dNTPs 2.5 µL 0.2 mM 
40 U/μl Ribolock RNase 
inhibitor 
0.15 µL 0.24 U/μl 
200 U/μl RT (reverse 
transcriptase) 
0.35 µL 2.8 U/μl 
25 mM MgCl2 2.5 µL 2.5 mM 
5 U/μl Taq DNA- 0.25 µL 0.05 U/μl 
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polymerase 
10 mM forward primer 
MDS-400 
2.5 µL 1 mM 
10 mM reverse primer 
MDS-402 
2.5 µL 1 mM 
Template 
 
2.5 µl of extracted viral 
RNA sample 
 
 
 
4.7.3 RT-PCR protocol used for the detection of sunshinevirus: 
Optimization of an RT-PCR protocol was carried out based on a previously 
published protocol provided kindly from Dr. Tim Hyndman (2012a). 13.5 µl from the 
total extracted viral RNA was added to 1 µl of reverse primer named Sunshine 
AS1: 5’ATTCAACATC-TGGGGTC (Hyndman et al., 2012a) and 1 µl of dNTPs and 
incubated at 65°C for 5 minutes. 0.5 µl of RT enzyme and 4 µl 5 x Puffer were then 
added to make a final volume of 20 µl and incubated at 25°C for 5 minutes, 24°C 
for 45 minutes and 70°C for 15 minutes. For PCR amplification, a 20 µl master mix 
was prepared (Table 4.5) containg reverse primer Sunshine AS1 and Sunshine S2 
5’TTCAAGGAGAT-AACCAGG (Hyndman et al., 2012a). Cycling descriptions 
initiated with denaturation at 94°C for 2 min, followed by 40 cycles of 94°C for 20 
sec., 45°C for 45 sec., 72°C for 30 sec ended with cooling at 4°C. PCR products 
were visualised using agarose gel electrophoresis. The expected product size was 
approximately 357 nucleotides.  
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Table 4.5 Chemicals and reagents used in the RT-PCR for the detection of sunshinevirus in snakes 
 
Reagent 1st round RT-
PCR 
Final 
concentration 
Reagent 2nd round RT-
PCR 
Final 
concentration 
 volume in 20 µl 
total amount 
  volume in 20 
µl total amount 
 
10 mM dNTPs 1 µl 0.5 mM Millipore water 7.1 µl  
1 mM Reverse primer 1 µl 0.05 mM 10x buffer + KCL 2 µl 1x 
Template 
 
13.5 µl of 
extracted viral 
RNA sample 
 Template 1µl of the 1st 
round RT-
PCR products 
 
5x Transcriptor reaction 
buffer 
4µl 1x 25 mM MgCl2 
 
3 µl 3.75 mM 
200 U/μl RT (reverse 
transcriptase) 
0.5 µl 5U/ µl 2 mM dNTPs 2.5 µl 0.25 mM 
   10 mM forward 
primer 
2 µl 1 mM 
   10 mM reverse 
primer 
2 µl 1 mM 
   
5 U/μl Taq DNA-
polymerase 
0.25 µl 0.0625 U/μl 
   40 U/μl Ribolock 
RNase inhibitor 
0.15 µl 0.3 U/ µl 
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4.7.4 RT-PCR positive controls 
Table 4.6 The positive controls used in the RT-PCRs    
 
Lab. No. Source  
Picornavirus virus (X) 144-10, 36-10  Dr. R.E. Marschang (Hohenheim 
University,Germany) 
Arenaviruses 128-1,2,3,4-12  Dr. Kim Heckers (Laboklin, 
GmbH & Co. KG, Germany) 
Sunshinevirus P8, P10 Dr. T. Hyndman (Murdoch University, 
Perth, Western Australia) 
  
4.8 Gel electrophoresis 
1.5% agar solution was prepared by dissolving 1.5 g agar in 100 ml 1x TAE- buffer 
followed by heating in a microwave for about 2 min. After heating, the solution was 
supplemented with 5 μl of ethidium bromide solution and shaken slightly. The mixture 
was then poured into a rectangular chamber provided with a comb and left to solidify for 
about 20 minutes at room temperature. After drying, the comb was removed and the gel 
was placed in the gel chamber and immersed in 1x TAE- buffer. 2µl loading dye (6 x) 
was mixed with 8µl of each of the final PCR products and pipetted into the gel slots. 3µl 
of DNA size ladder (100 bp DNA ladder or DNA ladder mix, based on the expected 
length of the products) was added to at least two side slots of each row. Gel 
electrophoresis was run for about 20-30 min at about 110 Volt; DNA was then visualized 
with a 320 nm UV-trans-illuminator. 
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4.9 Gel extraction  
With the use of surgical blades, the bands of the fourfold volume of PCR amplicons 
were incised accurately under visualization on the UV-transilluminator (the whole 
process should not exceed more than 30 seconds). Each band was put in a 2 ml micro-
centrifuge tube (previously weighed and numbered).  
Gel extraction was carried out according to the protocol provided by the manufacturer 
for the peqGOLD Gel-Extraction Kit (PEQLAB Biotechnology GmbH, Erlangen, 
Germany) as follows:   
1. After supplying each gel slice with an equal amount of Binding Buffer , the tubes were 
incubated on a heating block at 65°C, (vortexed every 3 min) until the gel was totally 
dissolved. The pH of the solution was controlled based on its color; if it was orange or 
red instead of yellow, about 5 μl of 5 M Na-acetate were added and vortexed 
immediately.   
2. 700 µl of the solution was then pipetted onto Perfect Bind DNA columns with a 
membrane for adsorption of DNA, which were plugged into collection tubes. The tubes 
were centrifuged with Varifuge 3.2 RS at 10,000 rpm for 1 min and the flow-through was 
discarded. If the solution was more than 700 µl, the process was repeated using the 
same collection tubes and columns.   
3. Columns were washed once with 300 μl Binding Buffer and twice with 300 µl Wash 
Buffer supplemented with EtOH. Prior to centrifugation (1 min at 10,000 rpm), the 
columns were incubated for about 2 min at room temperature.   
4. For drying the columns, a further centrifugation step (same conditions as above) was 
applied. The collection tubes were then discarded and the columns were placed into 
fresh 1.5 ml micro-centrifuge tubes.   
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5. For elution of the DNA from the membrane, 15 μl Elution Buffer was added (exactly 
on the membrane), the tubes were then incubated for about 2 min at room temperature. 
After that, the tubes and the membrane were centrifuged for 1 min at 5,000 rpm. This 
elution step was repeated once to get a final volume of about 30 µl of the extracted DNA 
which was stored at 4ºC until sequencing.    
All steps used for gel electrophoresis were carried out with all extracted DNA samples 
to determine the efficiency of the gel purification, by mixing 2 μl of each purified sample 
with 8 μl 1x concentration loading dye.  
 
4.10 Sequencing 
Gel purified PCR amplicons were diluted (1:2-1:20), based on the strength of the band 
visualized on the UV-transilluminator. 15 μl of the diluted samples and 20 μl of the 
corresponding PCR primer were submitted to a commercial service for sanger 
sequencing (Eurofins, MWG Operon, Ebersberg, Germany).  
 
4.11 Analyses of sequences   
Initial sequences were first downloaded from the website of the company 
http://www.eurofinsdna.com/de/home.html and processed by ABI Sequence Analysis 
Programme 5.1.1 (Applied Biosystems, Foster City, USA). For processing DNA 
sequences several software programs were used:  
1. Staden Package version:1.7.0 (2003.0) Pregap4 and Gap4 programme (Bonfield et 
al., 1995) for sequence assembly, editing, correcting and comparon. The sequences 
were compared to the data in GenBank (National Center for Biotechnology 
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Information, Bethesda, USA) online (www.ncbi.nih.gov) using the BLASTN and 
BLASTX homology search programs. 
2. BioEdit 7.0.5.3 (2005). Multiple alignments of sequences were performed with 
ClustalW algorithm of the BioEdit Sequence Alignment Editor programme (Hall, 
1999) using default settings. Identity matrices were generated as well. 
3. PHYLIP program Package, Versions 3.6 (University of Washington, Felsenstein, 
1989). Alignments were used for phylogenetic calculations applying DNAdist and 
Fitch programs to obtain an optimal tree. 
4. TOPALi v2.5 program (Biomathematics and Statistics Scotland) used for Bayesian 
analysis which was carried out from deduced amino acid (aa) and nucleotide (nt) 
alignments with their homologues derived from GenBank, using CPRev+G and 
HKY+G substitution models in MrBayes (Huelsenbeck & Ronquist, 2001) assuming 
gamma distribution with 100 generations, sample frequency 10 and burn in ratio 
25% to configure an optimal tree showing the posterior probability and maximum 
likelihood values. Bootstrapping was carried out with 100 replicates to estimate the 
validity of trees.  
5. FigTree v1.4.2. is a graphical viewer program of phylogenetic trees, which was used 
to optimize the graphic visualization of tree produced using the above named 
programs. 
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5. Results 
5.1 Picornavirus detection  
5.1.1 Cell culture and RT-PCR Trials  
5.1.1.1 Picornavirus (previously known as virus “X”) isolates 
37 virus “X” isolates from different years (see Table 4.1) were used in the study to test a 
variety of RT-PCRs. The isolates had been identified as possible virus “X” candidates 
based on their growth in TH1 causing a characteristic cell lysis and lack of sensitivity to 
chloroform (Marschang, 1999). Each isolate was inoculated onto TH1 using the 
methods described earlier (section 4.4) to yield more virus stock utilized for the study.  
After two days, virus growth and CPE were observed in all of the inoculated cell 
cultures. In all cases, CPE was characterized by cell lysis of the TH1 cells (Fig. 5.1). 
Cell cultures were frozen at -20°C to harvest the viruses and then collected in tubes to 
be used for RNA extraction and RT-PCR.  
Five primer sets were tested in RT-PCRs for their specificity and sensitivity (Table 4.2). 
Not all of the primer sets produced PCR products. In some trials, no PCR products or 
unspecific PCR products were produced (Table 11.1 in appendix). Among all primers, 
primer pair (FKei2 - RKei2) was the most widely reactive as it produced the highest 
number of positive PCR products (26 isolates were positive, 70%) from the 37 virus “X” 
isolates tested and amplicons with the expected size (400 bp) were all specific for 
picornaviruses  in all cases in which amplicons were obtained. The other primer sets 
(Kei+4343, FVX1-RVX1, FVX2-RVX2, Ftgt1-Rtgt1) were only tested based on their 
performance on the isolates, no diagnostic samples were screened with these primers. 
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Figure 5.1 microscopic views of cytopathic effects (CPE) of a virus “X” isolate  
(A): uninoculated TH1 cells  (B): 2nd passage of a virus “X” isolate (lab. no. 9_05), 
2 days post inoculation (magnification: 400 x). CPE was characterized by significant cell 
lysis with multiple small round cells in the supernatant. 
 
The primer pair FVX1-RVX1 produced seven positive products from 37 virus isolates 
(18.9%), while primer set FVX2- RVX2 produced 12 positive products from 24 virus 
isolates (50%). Only two positive products from 23 virus isolates were found in the RT-
PCR using the Kei+4343 primers (8.3%) and four positive products resulted from 37 
virus isolates (10.8%) using the Ftgt1 - Rtgt1 primer pair (Table 11.1 in appendix). All 
resulting amplicons were purified and sent to be sequenced. No host specificity was 
observed, viruses were founded in several different tortoise species.  
 
5.1.1.2 Diagnostic samples 
RT-PCR was performed for the detection of picornaviruses using the FKei2-RKei2 
primer set to screen 74 different samples and swabs from tortoises which were 
submitted to the laboratory between 2012 and 2013 for diagnostic purposes. Performing 
RT-PCR using the primer set Kei2 led to the detection of picornaviruses in six samples 
(8% of 74 diagnostic samples tested) originating from three tortoises (5.8% of 51 
A B 
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tortoises screened). From diagnostic samples collected in 2012, one picornavirus was 
isolated on TH1 cells from the head of a Stigmochelys pardalis sent from Italy. In 2013, 
two picornaviruses were isolated on TH1 cells from samples of organs (liver, kidney, 
heart, and lung) and an oral swab from two tortoises from Germany (see Table 11.1 in 
appendix). The RT-PCR successfully detected picornaviruses in RNA from tissues from 
these cases. Unfortunately, there were no clinical reports available for these tortoises, 
only the tortoise from sample 36_13 was infected with pinworms (Oxyuris spp.) and had 
high uric acid values. All three tortoises were negative for ranaviruses, herpesviruses 
and adenoviruses by PCR. 
 
5.1.2 Sequence analysis 
All amplicons were sequenced and the sequences identified using BLAST on the NCBI 
web site (www.ncbi.nlm.nih.gov/BLAST). The BLASTn results showed 93% identity with 
Saffoldvirus complete genome, while BLASTx results showed 57% identity with 
polyprotein of Mouse Mosavirus. Partial sequences of 26 picornavirus isolates were 
obtained from the RT-PCR using the primer pair FKei2 and RKei2 which targets 400bp 
of the polyprotein gene. Multiple alignments of the acquired nucleotide sequences of the 
isolates were successfully performed and an identity matrix was constructed with 
identity values of 79.2 – 100% (Table 11.3 in appendix). Multiple alignments of the 
obtained isolate sequences were performed comparing these with the corresponding 
nucleotide sequences of a portion of the polyprotein gene at nucleotide positions 6400–
7700 from four picornaviruses, members of the family Picornaviridae, which were used 
in this study for the comparison: Canine picornavirus (CanPV: JN831356) which is listed 
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as an unassigned picornavirus, Human enterovirus 109 (HEV: GQ865517), Human 
rhinovirus C (HRV: HM485529), and Human coxsackievirus A13 (HCV: DQ995642) 
which belong to the genus Enterovirus. All appeared to have relative similarities with the 
obtained sequences and the identity values ranged between 38.5-50.9 %. 
 A phylogenetic distance tree was constructed based on the multiple alignments of 308 
nucleotides (Figure 5.2) and showed a close genetic relationship among the detected 
picornavirus isolates and the tree illustrates two main clusters, which together form a 
single monophyletic cluster.  
Sequence analysis was also done on the amplicons obtained using the other primer 
sets (Kei+4343, FVX1-RVX1, FVX2-RVX2, Ftgt1-Rtgt1). Blast N of the sequences 
confirmed that each of the PCRs was specific. Similarity values of the obtained viral 
sequences of the polyprotein gene vary, and relative similarity was observed in the 
corresponding gene sequences of picornavirus members including: Human cosavirus D. 
Theiler's-like virus, Saffold virus, Cardiovirus, Rhinitis B virus and Mouse Mosavirus. 
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Figure 5.2 DNA distant tree based on 308 bp of the partial polyprotein gene of virus “X” isolates. 
Four picornaviruses were used as outgroups by applying DNAdist and Fitch programs of the 
PHYLIP program Package version 3.6. GenBank accession numbers: Canine picornavirus 
(CanPV: JN831356), Human enterovirus 109 (HEV: GQ865517), Human rhinovirus C (HRV: 
HM485529) and Human coxsackievirus A13 (HCV: DQ995642). 
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5.2 Arenavirus screening in snakes  
In this study, 450 swabs, tissues and organ samples from 170 snakes all from the 
families Boidae and Pythonidae (Table 11.5 in appendix) were screened for the 
detection of reptarenaviruses. 129 samples (28.6%) appeared positive with specific 
sized amplicons (300 bp) in the RT-PCR. Positive samples originated from 49 snakes 
(28.8%), 40 boa constrictor (81.6%) and 9 pythons (18.3%). A history of histological 
findings consistent with inclusion body disease (IBD) was reported for a number of 
cases (Table 11.4 in Appendix). 17 of 20 IBD positive animals (85%) (in addition to two 
samples in which IBD was diagnosed in the animal collection) were arenavirus positive 
by RT-PCR. 16 of 43 IBD negative animals were arenavirus positive (39.5 %), in 8 of 
these the reptarenavirus was found in brain samples, in 3 in oral swabs and in 6 in 
whole blood samples but not in other tissues. 14 of 93 animals with unknown IBD status 
were arenavirus positive (15 %). Most of the samples were submitted to the 
veterinarians to determine and examine the IBD status by cytology and/or histology. No 
host specificity was observed, arenavirus was found in both boas and pythonsbut 
different prevelances. 
Statistical data concerning snake screening, arenavirus detection, IBD status in tested 
snakes as follows (details shown in Table 11.4 in appendix): 
• 170 snakes,  450 samples subjected to RT-PCR 
• 129 arenavirus positive samples 
• 321 arenavirus negative samples 
• IBD pos.:  20 of which arenavirus pos: 17 neg: 3 
• IBD neg.:  43 of which arenavirus pos: 16 neg: 27 
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• IBD unknown.: 90 of which arenavirus pos: 13 neg: 79 
• IBD ?:   3 of which arenavirus pos: 1 neg: 2 
• IBD in collection: 12 of which arenavirus pos: 2 neg: 10 
 
5.2.1 Sequence analysis 
187 bp of the glycoprotein gene of the detected arenaviruses were obtained from 
arenavirus positive RT-PCR products. Multiple alignments of the acquired sequences 
showed high identity values between 72.7-100% among the detected viruses, while the 
nucleotide identity values of the detected arenaviruses with reptarenaviruses  were as 
follows: 75.9-98.3% identical with the corresponding portion of Golden Gate virus (GGV) 
(Alethinophid 1 reptarenavirus) genome (GenBank accession number: JQ717264), 77-
100% identical with the corresponding portion of the Boa Arenavirus Netherlands (Boa 
AV NLB3) (Alethinophid 3 reptarenavirus) genome (GenBank accession number: 
KC508669), 71.6- 80.7% with the corresponding portion of the University of Helsinki 
Virus (UHV) (Alethinophid 3 reptarenavirus) genome (GenBank accession number: 
KF297880), and 71.1- 78.6% identical with the corresponding portion of the California 
Academy of Sciences (CASV) (Alethinophid 2 reptarenavirus) genome (GenBank 
accession number: JQ717262) (Table 11.6 in appendix). A phylogenetic tree was 
calculated based on NT sequences to demonstrate the distance and clustering between 
the detected viruses and the snake arenaviruses GGV, Boa AV NLB3, UHV and CASV 
(Figure 5.3). In the tree, a majority of the detected reptarenavirus strains clearly 
clustered with GGV, Boa AV NL and UHV. None of the detected virus clustered with 
CASV. 
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Figure 5.3 DNA distance tree of the detected arenaviruses in snakes (Boas and 
Pythons) based on a 187 bp portion of the glycoprotein gene (GP2). Posterior 
probability values over 60 of 100 replicates are indicated beside the node. Branches 
with lower values are drawn with checkerboard lines. The maximum likelihood and the 
Bayesian analysis resulted in the same topology tree as the FITCH analysis. 
GenBank accession numbers: Golden Gate Virus (GGV JQ717264), Boa Arenavirus 
Netherlands (Boa AV NLB3 KC508669), California Academy of Sciences (CASV 
JQ717262) and University of Helsinki Virus (UHV-1 KF297880) 
Boa Av DE includes a group of samples with lab numbers as follows: 
Boa Av DE1 = 11_1_13S 
Boa Av DE2 = 11_11_13S, 11_12_13S, 11_13_13S, 11_14_13S, 11_16_13S, 
11_11_13B, 11_13_13B, 11_14_13B, 11_16_13B 
Boa Av DE3 = 11_25_13S, 11_25_13B 
Boa Av DE4 = 44_21_13 
Boa Av DE5 = 11_23_13S 
Abbreviation  S: pharyngeal swab  B: whole blood 
Group 14_1_13 includes arenaviruses detected in different organs: gut, liver, lung, 
pancreas, spleen and kidney.  
Group 14_2_13 includes arenaviruses detected in different organs: gut, liver, lung, 
pancreas, and kidney.  
Group 14_3_13 includes arenaviruses detected in different organs: lung, skin and brain. 
Group 14_7_13 includes arenaviruses detected in different organs: liver, spleen, 
trachea and kidney. 
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5.3 Detection of Sunshinevirus in snakes 
 Multiple RT-PCR trials were done to optimize the PCR for the detection of 
sunshinevirus using previously described primer sets and cycling conditions 
(Hyndman et al., 2012a). Positive bands from PCR products were consistantly 
weak. However, four of 38 samples (10 %) originating from three animals (25% 
of 12 animals tested) clearly displayed positive signals at the specific size (357 
bp) and were sent for sequencing. Sequencing results of the detected viruses 
were subjected to BLASTN analysis and were all 95- 98 % identical to the 
corresponding portion of the Reptile sunshinevirus 1 genome (Genbank 
accession number: JN192445). RNA samples P4 and P8, which were the 4th and 
the 8th passage on VH2 cell lines of an original sunshinevirus isolate, in addition 
to RNA samples of Mia and Tia (original sunshinevirus isolates provided by Dr. 
Hyndman, Murdoch University, Perth, Australia), were all used successfully as 
positive controls in the RT-PCR.  Multiple alignments of the obtained sequences 
were performed to compare the detected sunshineviruses with each other and 
with the complete genome of the original sunshinevirus as well (Fig.11.3 in 
appendix). The obtained sequences matched nucleotide positions 12578-12933 
of the original sunshinevirus. The detected viruses are highly similar to the 
original sunshinevirus (Table 5.1). The viruses were found in skin sample and 
oral-cloacal swabs of pythons, all boas tested were negative. Clinical signs 
reported in the animals infected with sunshinevirus vary significantly, but mostly 
respiratory problems were reported. 
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Table 5.1 Identity values (%) of the detected sunshinevirus in snakes in 
Germany 
(16_13H: 16_13 Haut): sunshinevirus was found in skin. The upper diagonal 
refers to the values for 148 nucleotides. The lower diagonal shows values for 49 
deduced amino acids of the detected viruses. 
 
Seq. 81_1_12,81_2_12, 
89_12, Milla,P4,P8 
16_13H Tia 
81_1_12, 81_2_12, 
89_12, Milla, P4, P8 
  89.1 99.1 
16_13H 80  88.5 
Tia 100 80  
Sunshinevirus 100 80 100 
 
 
Table 5.2 Data collected for sunshinevirus RT-PCR from diagnostic samples 
2012-2013 
Species Sample PCR  Clinical signs Lab no. 
1. Ball python 
Python regius 
lung lavage 
oral/tracheal 
swab 
pos. 
pos. 
dyspnea, 
weight loss,  
flagellates 
81_1-2_12 
2. Ball python 
Python regius 
oral/ cloacal 
swab 
pos. dyspnea, 
stomatitis 
89_12 
3. Indian python 
Python molurus 
n.a. neg. weak, nasal 
discharge 
38_1_13 
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4. Boa constrictor 
 
pancreas 
kidney 
brain 
lung 
heart 
Unspecific 
sized 
 bands 
weak 
 
38_2_13 
 
5. Garden tree boa 
Corallus hortulanus 
organs 
 
neg. 
 
dead,  
strangled by 
partner boa  
34_1-7_13 
6. Ball python 
Python regius 
lung lavage neg. were in 
contact with 
snakes 
infected with 
sunshinevirus  
26_1-2_13 
7. Anaconda 
Eunectes murinus 
n.a unspecific 
sized band 
n.a 24_9_13 
8. Ball python 
Python regius 
 
brain 
lung 
kidney 
skin 
liver 
neg. 
neg. 
neg. 
neg. 
neg. 
n.a 23_1-5_13 
9. Ball python 
Python regius 
 
Lung lavage unspecific 
sized 
 band 
pneumonia, 
was in contact 
with infected 
 snake 
(137_12) 
9_13 
10. Ball python 
Python regius 
 
kidney(isolated) 
lung 
liver 
unspecific 
sized 
 bands 
n.a 8_5_13 
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11. Ball python 
Python regius 
 
lung 
liver 
brain 
gut 
unspecific 
sized bands  
pneumonia 137_1-
4_12 
12. Ball python 
Python regius 
 
lung 
liver 
brain 
skin 
kidney 
gut 
pancreas 
unspecific 
sized 
 bands 
 
skin: pos. 
catarrhal –
purulent 
 pneumonia 
16_13 
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6. Discussion and conclusion  
6.1 Picornaviruses in Tortoises  
Since reptile picornaviruses have only recently been characterized, there are 
limited references available about picornavirus in tortoises. It is commonly known 
that picornaviruses caused diseases in mammals, but they have also been found 
in reptiles, birds, fish, plants, insects, and even algae (Ng et al., 2015). The 
family Picornaviridae has been expanded greatly in recent years, and now 
includes at least 35 genera with a rapidly expanding number of new picornavirus 
genera (ICTV 2017). Sequence analyses of tortoise picornavirus genomes 
showed that they did not belong to any previously recognized genera. An initial 
proposal was to create a new genus with the name Topivirus (Farkas et al., 
2015, Marschang et al., 2016). The genus finally established by the ICTV and is 
now named Torchivirus (Zell et al., 2017). At the same time, a genetically distinct 
picornavirus has been identified in Forsten's or Sulawesi tortoises (Indotestudo 
forsteni). This virus also appears to belong to a novel genus with the proposed 
name Rafivirus A (Ng et al., 2015). 
The purpose of this study was to develop a convenient diagnostic technique 
using reverse transcription polymerase chain reaction for the detection and 
identification of picornaviruses in terrestrial tortoise species. Virus diagnostic 
procedures using cell culture are limited by the expertise of the diagnostic 
laboratory and the time required obtaining a result. As such, viral culture has a 
limited place in routine diagnostic microbiology, although it is an effective 
diagnostic method and was previously the only reliable tool for the detection of 
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picornaviruses (Farkas et al., 2015). It is, however, difficult to visualize virions in 
infected cell cultures via electron microscopy, making virus identification 
dependent on the typical cytopathic effect (CPE) and resistance to chloroform 
(Heuser et al., 2010). Therefore, the development of a diagnostic (RT)-PCR 
assay was considered necessary for the detection and preliminary 
characterization of these viruses as a useful laboratory diagnostic tool. 
Sequencing portions of viruses has contributed to taxonomic classification of new 
viruses in this new genus. Future work might also be able to widen our 
understanding of the possible factors involved in viral pathogenicity. Sequence 
analysis can also provide the potential for understanding the genetic basis for 
presence or lack of species specificity. 
Although all isolates appeared positive in the TH1 cell culture, not all of them 
produced RT-PCR positive results. This could be due to the use of primer sets 
that did not match the genomic sequences of all viruses. The reaction of the PCR 
using the primer set Kei +4343 was low. The other primer sets tested were also 
unable to detect all of the isolates included in the screening. There are several 
possible reasons for this. Since the preliminary identification of the isolates used 
in this study was based on relatively unspecific criteria (type of CPE and 
resistance to chloroform), it is possible that some of the virus isolates tested were 
not picornaviruses. It is also possible that these virsues are highly variable, 
especially since they are ssRNA viruses, and that the primers designed during 
the course of this study did not bind to the specific sites in some cases. 
Sequencing of the PCR products produced using the primers (FKei2 and RKei2) 
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showed the highest sequence similarity values (33-85%) with the corresponding 
polyprotein gene of members of the genera Cardiovirus (includes serotypes 
Saffold virus and Theiler-like virus), Mosavirus and Cosavirus. These findings 
agree totally with those reported by Farkas et al. (2015) for a similar set of 
viruses.  
This RT-PCR protocol using the primer set Kei2 targeting a small portion of the 
polyprotein gene was useful for the detection of picornaviruses in terrestrial 
tortoises mainly in tortoises belonging to the Testudinidae family. Sequencing of 
the PCR products indicate that this protocol is very specific, because there were 
no unspecific products or unexpected bands produced by the RT-PCR. 
Marschang et al. (2016) also described the development of a RT-PCR protocol in 
which the picornavirus specific primer sets amplified 2 regions of the genome 
(containing a portion of the 5′-untranslated region, the leader peptide, and the 
VP4 capsid protein, and a portion of the picornaviral RNA-dependent RNA 
polymerase (3D), respectively). Both methods described there and methods 
developed in this study appear to be highly specific for torchiviruses, although 
further study is necessary to directly compare the naturally occurring torchivrus 
genotypes. In all cases, sequencing of each RT-PCR positive amplicon is highly 
recommended for a final diagnosis. 
According to phylogenic calculations, the viruses showed close genetic 
relationships between all of the isolates studied, and beside the typical CPE 
characteristic for these viruses, analysis of the obtained partial sequence data 
also confirmed that all strains belong to the genus Torchivirus. The viruses 
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appeared to be divided into two main lineages, with most of the strains belonging 
to the first lineage which contains four groups (Fig 5.2).  
Tortoise picornaviruses have been isolated from infected animals exhibiting 
various clinical signs (Table 11.1 in appendix). Consequently, there are no fixed 
signs indicating the presence of picornaviruses in tortoises and none of the 
previous studies have provided evidence relating to the pathogenicity of tortoise 
PVs. In addition, the detection of picornaviruses in samples from healthy animals 
could indicate that these viruses may lead to undetectable transmission by 
asymptomatic animals in animal collections. It is important to mention that 
previous studies indicate that these viruses might be involved in kidney disease 
and softening of the carapace in juvenile tortoises and possibly in various 
disease syndromes in adults including upper respiratory disease and sudden 
death (Heuser et al., 2014; Marschang and Ruemenapf, 2002). 
In order to prevent the spread of picornaviruses in a collection, a quarantine 
period would be necessary to observe and test newly acquired animals. Based 
on the data collected on the picornavirus isolates in this study, there was no strict 
host specificity and no association could be observed between the geographic 
distribution of the hosts and the genetic sequences, although the origin of the 
tested animals were all from within Europe including Germany, Italy, England and 
Switzerland. However, the pet trade may influence the distribution of pathogens 
in pet tortoises in these countries (Marschang et al, 2016). In any case, no 
significant relationship was noted between the geographic distributions of the 
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host animals. Therefore, further study is necessary to understand the global 
distribution of these viruses. 
 
6.2 Arenaviruses in snakes 
Arenaviruses were originally known as a group of mainly rodent-borne viruses 
which infect mammals and can cause a variety of serious diseases (Buchmeier 
et al., 2007). Recently, four novel arenavirus genomes were sequence from 
tissues of snakes diagnosed with Inclusion body disease (IBD) (Bodewes et al., 
2013; Stenglein et al., 2012; Hetzel et al., 2013). IBD is considered one of the 
most important diseases of snakes mainly because of its very high rate of 
mortality, and the lack of treatment and prevention options. The disease is 
infectious and commonly affects captive snakes of the families Boidae (boas and 
anaconda) and Pythonidae (pythons) (Schumacher et al., 1994; Wozniak et al., 
2000; Jacobson et al., 2001). 
The identification of arenaviruses from various snake samples in the present 
study is the first report in live snakes in Germany. This is also the first description 
of the detection of arenaviruses in pythons including reticulated python, green 
tree python, ball python and Indian python (Table 11.4 in appendix). 28.6% of the 
screened samples were positive using the described RT-PCR and all of the 
viruses detected were closely related to recently described viruses in the new 
genus Reptarenavirus which contains three species: Alethinophid 1 
reptarenavirus  (member virus: Golden Gate virus), Alethinophid 2 reptarenavirus  
(CASV), and Alethinophid 3 reptarenavirus  (University of Helsinki virus 1 
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[UHV1], boaAVNLB3 virus). The detected arenaviruses in this study all grouped 
together with GGV and BoaAVB3 and UHV. Moreover, Hepojoki et al. (2015) 
presented a study which demonstrates the identification of four novel 
representatives of Reptarenavirus from boa constrictors. This indicates that the 
recently established genus is likely to expand in the near future. Studying genetic 
diversity of arenaviruses infecting captive snakes is very important for the future 
to understand viral evolution as well as the development of IBD in infected 
snakes. Stenglein et al. (2015) documented viral genetic complexity of naturally 
infected snakes and pointed out that the majority of snakes were infected with 
multiple reptarenavirus genotypes and a spectacular amount of viral diversity 
was reported as well as viral recombination and re-assortment. 
 Most of the positive results in the present study were found in apparently healthy 
snakes. It is possible that (as is often the case in rodents) arenavirus infection of 
snakes is chronic and sub-clinical (Stenglein et al., 2012). Besides the IBD 
history reports of the arenavirus positive snakes, clinical signs including CNS 
signs, respiratory signs, inappetence and skin problems were reported in a few 
cases in our study. Moreover, other studies suggest that reptarenaviruses may 
establish chronic infections in snakes, and that co-infections or super-infection 
with other reptarenaviruses in chronically infected snakes might be relevant for 
the pathogenesis of IBD, due to immune-suppression (Hepojoki et al., 2015). The 
absence of clinical signs in some animals with IBD has been described. 
However, a method for early detection of viral infection is necessary in order to 
develop effective screening and quarantine procedures as well as to increase 
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understanding of virus pathogenicity. Virus strain, host factors, and infection time 
may all also play a role in virus shedding and disease development (Aqrawi et 
al., 2015). Two of 12 snakes which were found to be in contact with IBD infected 
snakes were arenavirus positive, indicating possible transmission within 
collections. 
The identification of protein inclusions in tissues or blood films has been the 
standard diagnostic method for IBD for decades. While many snakes with IBD 
may have many inclusions in different tissues (Jacobson, 2007), some snakes 
may have few, which are limited to certain organs and are easily overlooked. 
Furthermore, inclusions resembling those seen in IBD have been seen in snakes 
with other viral diseases, and distinguishing them from IBD inclusions can be 
challenging (Bodewes et al., 2013; Raymond et al., 2001; Jacobson, 2007). In 
our study we used microscopic examination of blood smears or tissue sections to 
identify inclusions as a common IBD diagnostic method (done by Dr. K. Heckers 
in Laboklin GmbH & Co. KG, Bad Kissingen, Germany). Since 39.5 % of the IBD 
negative animals were arenavirus positive, further study is needed to determine if 
arenavirus infection always eventually leads to the development of IBD or if some 
animals may be able to clear infection and not develop disease. On the other 
hand, three of 20 snakes diagnosed as IBD positive in this study tested negative 
for arenavirus infection. This may indicate infection with other divergent 
arenaviruses not detected by the methods used. Other explanations are testing 
of inappropriate samples in which no virus was present or degradation of viral 
RNA during transport and/or preparation. The development of sensitive methods 
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for the detection of arenaviruses in live snakes will facilitate the identification of 
infection prior to the development of clinical disease and lower the chances for 
the introduction of these viruses into new collections. 
 
6.3 Sunshinevirus in snakes 
When it was first described, sunshinevirus was hypothesized to be a novel 
paramyxovirus and was shown to be distantly related to the ferlaviruses 
(Hyndman et al., 2012a). Ferlaviruses are enveloped RNA viruses which 
commonly cause infections associated with neurologic, respiratory and 
immunosuppressive diseases and have caused significant mortality in snake 
collections worldwide (Fry, 2015). In addition, Nidoviruses have recently been 
described as a cause of severe respiratory diseases in captive ball pythons and 
boas in the USA and Europe (Stenglein et al., 2014; Uccellini et al., 2014; 
Bodewes et al., 2014; Marschang and Kolesnik, 2016). The nidoviruses present 
a diverse order that includes important human and veterinary pathogens.  
Respiratory diseases in snakes are common in captivity. It can be very difficult to 
detect illness in live snakes due to the ability of these animals to hide clinical 
signs of disease. Therefore, some animals may appear clinically healthy despite 
suffering from e.g. pneumonia. In one study, acute catarrhal pneumonia was 
diagnosed more often in snakes without respiratory signs than in snakes with 
respiratory signs, and respiratory signs and pneumonia were detected more often 
in pythons than in boas (Schmidt et al, 2013). Establishment of effective 
diagnostic tools for the detection and differentiation of various causes of 
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neurological and respiratory disease in snakes is therefore of particular 
importance.  
 In 2016, the genetic differences between sunshinevirus and other 
paramyxoviruses led to the establishment of a new family “Sunviridae” within the 
order Mononegavirales. The family includes a single genus Sunshinevirus with a 
single species (Reptile sunshinevirus 1) (Alfonso et al., 2016). The initial 
detection of sunshinevirus was described in 2008 from a collection of 70 
Australian pythons which was experiencing an outbreak of neuro-respiratory 
disease on the Sunshine Coast of Queensland, Australia (Hyndman et al., 
2012b). The present study includes the first detection of sunshinevirus in snakes 
outside Australia. Affected species have mostly included Australian pythons 
mainly Antaresia sp., Morelia sp. and Aspidites sp. (Hyndman et al., 2012a). In 
Germany in this study sunshinevirus was found in three ball pythons (Python 
regius). Clinically, sunshinevirus has generally been associated with neuro-
respiratory disease, although other clinical signs have been reported as well 
including anorexia, stomatitis, weakness, regurgitation, skin problems like blisters 
and dermatitis have also been reported (Hyndman et al., 2014). Sunshinevirus 
was detected in four samples (lung lavage, oral swab, cloacal swab and in skin) 
from three ball pythons, each from a different private owner, which were 
presented for medical examination in southern Germany because they were 
suffering from dyspnea, weakness, stomatitis and pneumonia, two of which were 
still alive at the time of sampling (Anke Stöhr, personal communication). In a 
previous study, sunshinevirus was found most often in samples of brain, and 
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specific neuro-histopathological changes seem to serve as a reliable indicator of 
infection with sunshinevirus (Hyndman et al., 2014).  
Despite studies and reports focusing on detection of sunshinevirus in snakes 
which have been published in recent years, there are still important gaps in the 
knowledge concerning these viruses and their pathogenesis. For example, the 
incubation periods, propagation of the virus within reptilian hosts and 
transmission in animal collections, all are poorly understood and as a 
consequence, it is difficult to advise on the prevention and control of 
sunshinevirus infections. Because snakes are popular pets and their trade has 
increased in the last few decades, owners need to be aware of infectious 
diseases in these animals and how to deal with them. Until the epidemiology of 
these viruses is better understood, it is necessary to observe and test newly 
acquired animals during a quarantine period to avoid introducing potential 
pathogens into snake collections.  
 
In Conclusion: 
 
Tortoises and snakes are popular pets and interest in infectious diseases of 
these animals has grown in recent years. Reliable, fast and inexpensive 
diagnostic methods are important for improving animal health in captivity. This 
study has led to the establishment of conventional PCRs to detect new viruses in 
these animals (picornaviruses in tortoises, reptarenaviruses in snakes and 
sunshineviruses in snakes). Detection of these viruses in live animals can be of 
interest both in diseased animals as well as in clinically healthy animals. These 
viruses appear to be relatively common among tortoises and snakes in captivity 
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in Europe. Animal screening for these viruses should be considered, particularly 
for those animals in quarantine situations which would allow control of these 
infections in zoos and private collections. 
 
7. Summary 
The purpose of this study was to establish conventional reverse-transcriptase 
PCRs for the detection of recently described RNA viruses in reptiles. The viruses 
studied included picornaviruses of tortoises (torchivirus or virus “X”), 
reptarenaviruses and sunviruses in snakes.  
Picornaviruses are detected frequently in tortoises of various species in Europe. 
Until recently, tortoise picornaviruses (previously designated as virus “X”) could 
only be detected by isolation in Terrapene heart (TH1) cells in which they cause 
cell lysis, and nothing was known about the relationships of various isolates to 
one another. Clinical signs that have been described in picornavirus infected 
tortoises include softening of the shell in juvenile tortoises, rhinitis, conjunctivitis, 
kidney failure, and sudden death, but these viruses have also been detected in 
clinically healthy animals. This group of picornaviruses is able to infect a wide 
range of species in the family Testudinidae and has been detected in tortoises in 
many different European countries. 
In this study, a conventional RT-PCR was developed and established for the 
detection and identification of picornaviruses in clinical samples. To test the 
reliability of this RT-PCR as a diagnostic method and the several primer sets 
which were designed for this purpose (Table 4.7), 37 picornaviruses isolated 
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from swabs and tissue samples collected in Germany and Italy between 1997 
and 2012 were screened. The primer pair FKei2 (CTACCATCAGGATGCAGTT) - 
RKei2 (AAGCCAATCCTGCAACACT) gave the highest number of positive 
results from the chosen isolates (70%). 308 nucleotide long sequences of the 
amplified products of 26 picornavirus isolates were obtained which represent a 
small part of the viral polyprotein gene. Alignment of the obtained sequences 
from the amplified products revealed a close genetic relationship among the 
detected tortoise picornavirus isolates confirmed by the high identity values 
between 79.2 – 100% (Table 11.3 in appendix). Phylogenetic analysis clearly 
shows two main clusters, which together form a single monophyletic cluster. The 
obtained viral sequences of the polyprotein gene were compared with previously 
described picornaviruses and the highest similarities were observed with the 
corresponding gene sequences of picornavirus family members including: 
Canine picornavirus, Human enterovirus 109, Human rhinovirus C, and Human 
coxsackievirus A13. Based on sequence analysis, no association was observed 
between the geographic distribution and genetic relatedness. BLASTn analysis of 
the sequences confirmed that each of the PCRs with the different primer sets 
was specific. Furthermore, no strict host specificity was indicated. The PCR-
based diagnosis may provide a time-saving and sensitive method to detect 
tortoise picornaviruses and to help prevent viral spread among animal 
collections. 
A conventional RT-PCR was also established for the detection of arenaviruses in 
snakes and used to screen clinical samples from live and dead animals for these 
78 
 
viruses. The reptarenaviruses are considered to be the causative agent of 
inclusion body disease (IBD) which is a chronic progressive disease affecting 
captive boas and pythons worldwide. Samples from animals screened for virus 
detection were also screened for the presence of IBD typical inclusions in blood 
smears or histological preparations of 63 organs. The primer combinations MDS-
400 (5’-TTCATTTCTTCATGRACTTTRTCAATC-3’) and MDS-402 (5’-
GGSATAACAAAYTCACTTCAAATATC-3’) targeting part of the glycoprotein 
gene were used for the detection of reptarenavirus. 49 of 170 snakes tested 
(28.8%) were arenavirus positive. While 17 of 20 IBD positive snakes (85%) were 
arenavirus positive by RT-PCR, 17 of 43 IBD negative animals (39.5%) were 
arenavirus positive. Arenavirus was found in both boas (Boa constrictor) and 
pythons (Python regius, Malayopython reticulatus, Python molurus, and Morelia 
viridis). Alignment of the obtained sequences of a small portion of the 
glycoprotein gene from the detected arenaviruses showed high identity values 
between 71- 100% with previously described reptarenaviruses. Phylogenetic 
analysis indicated that a majority of the detected reptarenavirus strains clearly 
clustered with GGV, Boa AV NL B3 and UHV. None of the detected viruses 
clustered with CASV. 
Furthermore, this work includes a study concerning the first detection of 
sunshinevirus in snakes in Europe using RT-PCR as a diagnostic method. The 
first description of sunshinevirus was in 2008 after an outbreak of neuro-
respiratory disease in an Australian collection of 70 pythons.  
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The RT-PCR used in this study resulted in the detection of sunviruses in three 
out of 12 snakes tested (25%).  The obtained sequences were compared with the 
corresponding portion of the sunshinevirus genome and the identity values were 
between 95- 98 %. The viruses were found in oral/ cloacal swabs, lung lavage 
and skin sample of ball pythons, all other tested snakes were negative (two boas, 
one anaconda and one Indian python). Clinical signs reported in the animals 
infected with sunshinevirus vary significantly, but mostly respiratory problems 
were reported.  
 
 8. Zusammenfassung 
Ziel der vorliegenden Arbeit war Etablierung von konventionellen Reverse-
Transkriptase-PCRs für den Nachweis von den bisher bekanten RNA-Viren in 
Reptilien. Zu den untersuchten Viren gehörten Picornaviren in Schildkröten 
(Torchiviren oder virus "X"), Reptarenaviren und Sunviren in Schlangen. 
Picornaviren wurden bisher bei verschiedenen Schildkrötenspezies 
nachgewiesen im Europa am häufigsten werden sie bei Testudinidae gefunden.  
Bis vor kurzem, Picornaviren aus verschiedenen Proben von Landschildkröten 
wurde nur auf die Zelllinie Terrapene Heart cells (TH1) nachweisen und isoliert, 
dabei einen lytischen zytopathischen Effekt verursacht und nichts war bekannt 
über die Beziehung zwischen Vieren Isolaten. Zu den klinischen Zeichen 
gehören Panzererweichung bei Jungtieren, Rhinitis, Konjunktivitis, Nierenausfall, 
sowie plötzlichen Todesfällen, allerdings Picornaviren können gelegentlich auch 
bei scheinbaren gesunden Schildkröten nachweisen werden. 
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In dieser Arbeit wurde eine konventionelle RT-PCR entwickelt und festgestellt für 
die Diagnose und Identifizierung von Piconaviren in klinischen Tierproben. 37 
Picornaviren wurde isoliert vom Rachentupfer und von den verschiedenen 
Gewebeproben, diese wurden in Deutschland und Italien zwischen 1997 – 2012 
gesammelt. Alle Isolate wurden abgeschirmt für den Zweck überprüfen die 
Zuverlässigkeit dieser RT-PCR als Diagnostische Methode und überprüfen die 
verschiedenen Primer-Sets, die zu diesem Zweck entworfen wurden (Table 4.7). 
Das Primer paar FKei2 (CTACCATCAGGATGCAGTT) - RKei2 
(AAGCCAATCCTGCAACACT) hat die Mehrheit (70%) von der positiven 
Ergebnisse aus den ausgewählten Isolaten vorgelegt. Von 26 Picornaviren 
Isolaten Nukleotidsequenzen der amplifizierten Produkte wurde erhalten mit 
einer Länge von 308, und die einen kleinen Teil des viralen Polyprotein-Gens 
darstellen. Die Ausrichtung der erhaltenen Sequenzen aus den amplifizierten 
Produkten ergab eine enge genetische Beziehung zwischen den detektierten 
Schildkrötenpikornavirus-Isolaten, die durch die hohen Identitätswerte zwischen 
79,2 und 100% (Table 11.3 in Appendix). Die phylogenetische Analyse zeigt 
deutlich zwei Hauptcluster, die zusammen einen einzigen monophyletischen 
Cluster bilden. Die erhaltenen viralen Sequenzen des Polyprotein-Gens wurden 
mit den zuvor beschriebenen Picornaviren verglichen und die höchsten 
Ähnlichkeiten wurden mit den entsprechenden Gensequenzen von Picornavirus-
Mitgliedern beobachtet, einschließlich: Human cosavirus D. Theiler's-like virus, 
Saffold virus, Cardiovirus, Rhinitis B virus and Mouse Mosavirus. Nach der 
Sequenzanalyse, es wurde keine Verbindung zwischen der geographischen 
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Verteilung und der genetischen Verwandtschaft beobachtet. Die BLASTn-
Analyse der Sequenzen bestätigte, dass jede der PCRs mit den verschiedenen 
Primersätzen spezifisch war. Weiterhin es wurde keine strenge Wirtstierspezifität 
angegeben. Die PCR-basierte Diagnose kann eine zeitsparende und 
empfindliche Methode zur Erkennung von Schildkröten-torchivirusinfectionen und 
zur Vermeidung von Virusausbreitung unter Tierkollektionen bieten. 
Eine konventionelle RT-PCR wurde auch für den Nachweis von Arenaviren in 
Schlangen etabliert und verwendet, um klinische Proben von lebenden und toten 
Tieren für diese Viren zu untersuchen. Die Reptarenaviren gelten als Erreger der 
Inclusion Body Disease (IBD), die eine chronische bedeutende Erkrankung ist, 
die die Gefangenen Boas und die Pythons weltweit betrifft. Proben von Tieren, 
die auf Virenerkennung untersucht wurden, wurden ebenfalls auf die 
Anwesenheit von IBD-typischen Einschlüssen in Blutabstrichen oder 
histologischen Präparationen von 63 Organen untersucht. Die Primer-
Kombination MDS-400 (5'-TTCATTTCTTCATGRACTTTRTCAATC-3 ') und 
MDS-402 (5'-GGSATAACAAAYTCACTTCAAATATC-3'), die einen Teil des 
Glykoprotein-Gens ausrichten, wurden für den Nachweis von Reptarenavirus 
verwendet. 49 von 170 getestet Schlangen (28,8%) waren Arenavirus positiv. 
Während 17 von 20 IBD-positiven Schlangen (85%) waren Arenavirus positiv, 
waren 17 von 43 IBD-negativen Tieren (39,5%) Arenavirus positiv durch RT-PCR 
arenavirus. Arenaviren wurde in beiden Boas und Pythons gefunden, besonders 
in Python regius, Malayopython reticulatus, Python molurus und Morelia viridis. 
Die Ausrichtung der erhaltenen Sequenzen eines kleinen Teils des Glykoprotein-
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Gens aus den nachweisenden Arenaviren zeigte hohe Identitätswerte zwischen 
71- 100% mit zuvor beschriebenen Reptarenaviren. Die phylogenetische Analyse 
zeigte, dass eine Mehrheit der detektierten Reptarenavirus-Stämme eindeutig mit 
GGV, Boa AV NL B3 und UHV gruppiert war. Keines der erkannten Viren mit 
CASV gruppiert. 
Weiterhin, umfasst diese Arbeit eine Studie über die erste Erkennung von 
Sunsheinviren in Schlangen in Europa mit RT-PCR als diagnostische Methode. 
Die erste Beschreibung von Sunshinevirus war im Jahr 2008 nach einem 
Ausbruch der Neuro-Atemwegserkrankung in einer australischen Sammlung von 
70 Pythons. Die in dieser Studie verwendete RT-PCR führte zum Nachweis von 
Suniviren in drei von 13 getesteten Schlangen (23,1%). Die erhaltenen 
Sequenzen wurden mit dem entsprechenden Teil des Sunsheinvirus-Genoms 
verglichen und die Identitätswerte waren zwischen 95- 98%. Die Viren wurden in 
oralen / kloakalen Tupfern, Lungenspülung und Hautprobe von Ball python 
gefunden, alle anderen getestete Schlangen waren negativ (zwei Boas, eine 
Anaconda und eine indische Python). Klinische symptome, die bei den mit 
Sunshinevirus infizierten Tieren gemeldet wurden, deutlich variieren, aber 
meistens wurden Atemwegserkrankungen gemeldet.  
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11. Appendix  
 
 
 
 
 
 
 
Lab No. 
Isolates 
Host species Samples PCR with primer sets Origin Source/Case history 
Oligo 
dT18 
Kei+4343 
Rvx1 
Fvx1 
Rvx2 
Fvx2 
Rtgt1 
Ftgt1 
Rkei2 
Fkei2 
1. TGT1a/96 Spur-thighed tortoise 
 Testudo graeca 
n.a neg. neg. pos. pos. pos. n.a Isolate from Dr. 
Marschang  
2. 374/96 n.a ? (TH1 P6) n.d. neg. n.d. neg. neg. n.a Isolate from Dr. 
Marschang  
3. 33/97 Spur-thighed tortoise 
 Testudo graeca 
oesophagu
s 
n.d. neg. n.d. neg. neg. Germany Isolate from Dr. 
Marschang  
4. 2442/97 
TGT8 
Spur-thighed tortoise 
 Testudo graeca 
liver n.d. neg. n.d. neg. neg. Germany  Isolate from Dr. 
Marschang  
5. 907/97 
TGT10 
Spur-thighed tortoise 
 Testudo graeca 
heart n.d. neg. n.d. neg. neg. Germany Isolate from Dr. 
Marschang  
6. 2443/97 Spur-thighed tortoise 
 Testudo.graeca 
intestine n.d. neg. n.d. neg. neg. Switzerland Isolate from Dr. 
Marschang  
7. 2445/97 Egyptian tortoise trachea n.d. neg. n.d. neg. neg. Switzerland Isolate from Dr. 
Table 11.1 Data collected for tortoise picornaviruses (virus “X”), RT-PCR results from RNA isolates and from 
diagnostic samples. All PCR positive products were sequenced. 
n.d: not done n.a: not available  
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 Testudo kleinmanni Marschang  
8. 1791/98 Spur-thighed tortoise 
 Testudo graeca 
brain n.d. neg. n.d. neg. neg. Germany Isolate from Dr. 
Marschang  
9. 2281/7/98 Testudo spp. throat swab n.d. neg. n.d. neg. neg. Germany  Isolate from Dr. 
Marschang  
10. 2691/98 Leopard tortoise 
 Stigmochelys pardalis 
tongue n.d. neg. n.d. neg. neg. Germany Isolate from Dr. 
Marschang  
11. 1167/5/99 Tortoise tongue n.d. neg. n.d. neg. neg. n.a Isolate from Dr. 
Marschang  
12. 1167/9/99 Tortoise colon n.d. neg. n.d. neg. neg. n.a Isolate from Dr. 
Marschang  
13. 659/00 Hermann’s tortoise 
 Testudo hermanni 
tongue n.d. neg. n.d. neg. pos. n.a Isolate from Dr. 
Marschang  
Herpesvirus PCR  postive 
14. 2041/00 Russian tortoise 
 Testudo horsfieldi 
n.a n.d. neg. n.d. neg. pos. n.a Isolate from Dr. 
Marschang 
Herpesvirus found in 
same group of tortoises 
15. 5_03 Spider tortoise 
 Pyxis arachnoids 
lung  neg. neg. neg. pos. pos. n.a Isolate from Dr. 
Marschang  
16. 16_03 Testudo spp. kidney  neg. neg. neg. neg. pos. Italy  Isolate from Dr. 
Marschang  
17. 26_03 Marginated tortoise 
 Testudo marginata 
pharyngeal 
swabs 
neg. neg. pos. neg. pos. Italy  Isolate from Dr. 
Marschang  
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Death in collection 
following 
 introduction of Indian star 
tortoises 
18. 31_03 Hermann’s tortoise 
 Testudo hermanni 
tongue  neg. pos. pos. neg. pos. Germany  Isolate from Dr. 
Marschang study 
19. 2_4_04 Tortoise - neg. neg. neg. neg. pos. Germany  Isolate from Dr. 
Marschang  
Sudden death, fatty liver, 
diffuse mixed vacuolar 
hepatocellular fatty 
degeneration Mycoplasma  
agassizii PCR positive 
20. 5_04 Spur-thighed tortoise 
 Testudo graeca 
- neg. pos. neg. neg. pos. Germany Isolate from Dr. 
Marschang  
21. 14_04 Hermann’s tortoise 
 Testudo hermanni 
cloacal 
swab 
neg. neg. pos. neg. pos. Germany Isolate from Dr. 
Marschang  
Animals were clinically 
healthy, , but animals sold 
from this collection died in 
their new home 
Herpesvirus PCR 
negative 
22. 15_04 Spur-thighed tortoise tongue neg. neg. neg. neg. pos. Germany Isolate from Dr. 
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 Testudo graeca Marschang study 
Sudden death, shell 
softening, ascites, lung 
tissue thickened 
Herpesvirus PCR 
negative 
23. 16_04 Hermann’s tortoise 
 Testudo hermanni 
 boettgeri 
liver, small 
intestines, 
heart, lung 
neg. neg. neg. pos. pos. Germany Isolate from Dr. 
Marschang  
Shell softening, liver light 
and friable 
24. 17_04 Hermann’s tortoise 
 Testudo hermanni 
 boettgeri 
heart neg. neg. neg. neg. pos. Germany Isolate from Dr. 
Marschang  
Shell softening,  
Herpesvirus PCR 
negative 
25. 19_1_04 Hermann’s tortoise 
 Testudo hermanni 
- neg. neg. neg. neg. pos. England Isolate from Dr. 
Marschang  
Virus isolated from heart, 
liver and gonad. 
26. 19_2_04 Hermann’s tortoise 
 Testudo hermanni 
- neg. neg. neg. neg. pos. England Isolate from Dr. 
Marschang study  
Virus isolated from 
stomach 
, backbone, head, lung 
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and liver. both suffered 
from 
necrotising stomatitis,  
Multifocal-bronchitis 
/pneumonia 
27. 9_05 African spurred 
tortoise  
Centrochelys sulcata 
oral swab neg. pos. neg. neg. pos. Italy  Isolate from Dr. 
Marschang  
Stomatitis 
28. 25_09 Marginated tortoise 
 Testudo marginata 
- neg. pos. neg. neg. pos. Germany  Isolate from Dr. 
Marschang  
Clinically healthy 
29. 19_10 Russian tortoise 
 Testudo horsfieldii 
tongue 
swab 
neg. pos. neg. pos. pos. Germany Isolate from Dr. 
Marschang  
Red soft-shell, yellow 
plaque coating the mouth 
cavity 
30. 124_1_10 Spur-thighed tortoise 
 Testudo graeca 
oral& 
cloacal 
swabs 
neg. neg. pos. neg. pos. Germany  
 
Isolate from Dr. 
Marschang  
All were clinically healthy 
31. 124_2_10 Spur-thighed tortoise 
 Testudo graeca 
oral& 
cloacal 
swabs 
neg. neg. pos. neg. pos. 
32. 124_4-10 Spur-thighed tortoise  
Testudo graeca 
oral& 
cloacal 
neg. neg. pos. neg. pos. 
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swabs 
33. 124_5_10 Spur-thighed tortoise 
 Testudo graeca 
oral& 
cloacal 
swabs 
neg. neg. pos. neg. pos. 
34. 124_6_10 Spur-thighed tortoise  
Testudo graeca 
oral& 
cloacal 
swabs 
neg. neg. pos. neg. pos. 
35. 124_7_10 Spur-thighed tortoise  
Testudo graeca 
oral& 
cloacal 
swabs 
neg. neg. pos. neg. pos. 
36. 36_10 Marginated tortoise  
Testudo marginata 
oral& 
cloacal 
swabs 
pos. pos. pos. neg. pos. Germany  Isolate from Dr. 
Marschang  
Obstipation, gastirits 
37. 144_10 Spur-thighed tortoise  
Testudo graeca 
oral swab pos. pos. pos. neg. pos. Italy  Isolate from Dr. 
Marschang  
Suffered closed eyes for 
25 days.  
Blepharoconjunctivitis and 
glossitis 
38. 130_12 Leopard tortoise 
Stigmochelys pardalis 
head n.d. n.d. n.d. neg. pos. Italy  From diagnostic samples 
2012 
Herpesvirus PCR 
negative 
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39. 36_13 Tortoise  liver 
kidney 
heart 
lung 
n.d. n.d. n.d. neg. pos. 
pos. 
pos. 
pos. 
Germany  From diagnostic samples 
2013 
40. 62_13 Tortoise oral swab n.d. n.d. n.d. neg. pos. n.a From diagnostic samples 
2013 
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Table 11.2 Data from all tortoise samples received in 2012-2013 and screened for the detection of picornavirus virus “X” 
using RT-PCR with the primer set Kei2 with negative results  
 
 Lab.no. Species  Sample  Source  
1.  36_12 
 
Spur-thighed tortoise  
Testudo graeca 
n.a Uni Leipzig 
Germany 
2.  37_2_12 Russian tortoise 
Testudo horsfieldii 
n.a - 
3.  37_3_12 Tortoise n.a - 
4.  37_4_12 Tortoise n.a - 
5.  40_12 Hermann’s tortoise 
Testudo hermanni 
n.a - 
6.  42_12 Russian tortoise 
Testudo horsfieldii 
n.a - 
7.  43_1_12 Hermann’s tortoise 
Testudo hermanni 
n.a - 
8.  43_2_12 Tortoise n.a  - 
9.  44_12 Leopard tortoise 
Stigmochelys pardalis 
n.a - 
10.  46_12 Spur-thighed tortoise  
Testudo graeca  
n.a Italy 
11.  49_1_12 Russian tortoise n.a - 
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Testudo horsfieldii 
12.  49_2_12 Tortoise n.a - 
13.  53_1_12 Indian star tortoise 
Geochelone elegans 
n.a - 
14.  53_2_12 Indian star tortoise 
Geochelone elegans 
n.a - 
15.  53_3_12 Leopard tortoise 
Stigmochelys pardalis 
n.a - 
16.  53_4_12 Spur-thighed tortoise 
 Testudo graeca 
n.a - 
17.  56_12 Hermann’s tortoise 
Testudo hermanni  
n.a Italy 
18.  58_1_12 Elongated Tortoise 
Indotestudo elongata 
n.a - 
19.  58_2_12 Tortoise n.a - 
20.  69_12 Russian tortoise 
Testudo horsfieldii 
n.a - 
21.  72_12 Hermann’s tortoise 
Testudo hermanni 
n.a - 
22.  76_12 Hermann’s tortoise 
Testudo hermanni  
n.a Tübingen 
Germany 
23.  82-12 Russian tortoise n.a Achen 
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Testudo horsfieldii Germany 
24.  84_1_12 Aquatic turtule 
 
tracheal swab - 
25.  84_2_12 carapacial swab - 
26.  84_3_12 cloacal swab - 
27.  84_4_12 Aquatic turtule  trachea swab - 
28.  84_5_12 carapacial swab - 
29.  84_6_12 cloacal swab - 
30.  84_7_12 Aquatic turtule  trachea swab - 
31.  84_8_12 carapacial swab - 
32.  84_9_12 cloacal swab - 
33.  85_1_12 Hermann’s tortoise 
Testudo hermanni 
n.a - 
34.  85_2_12 n.a - 
35.  86_1_12 Tortoise colon 
lung 
small intestine 
liver 
spleen 
kidney 
skin 
- 
36.  86_2_12 Tortoise colon 
lung 
small intestine 
- 
107 
 
liver 
kidney 
37.  90_12 Hermann’s tortoise 
 Testudo hermanni 
n.a - 
38.  93_3_12 Tortoise 
Astrochelys yniphora 
n.a - 
39.  99_12 Russian tortoise 
Testudo horsfieldii 
n.a Uni Leipzig 
Germany 
40.  104_12 Marginated tortoise 
 Testudo marginata  
n.a - 
41.  10_13 Red-footed tortoises 
 Chelonoidis carbonaria 
swab 
 
Wilhelma 
Germany 
42.  47_1_13 Hermann’s tortoise 
 Testudo hermanni 
 
 
pharyngeal swab - 
43.  47_2_13 cloacal swab  - 
44.  42_13 spleen Uni Leipzig 
Germany 
45.  64_2_13 Tortoise liver Germany 
46.  64_3_13 brain Germany 
47.  64_4_13 lung Germany 
48.  64_5_13 kidney Germany 
49.  64_6_13 gut Germany 
50.  65_1_13 Hermann’s tortoise intestine Germany 
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51.  65_2_13 Testudo hermanni kidney Germany 
52.  65_3_13 spleen Germany 
53.  65_4_13 tongue Germany 
54.  65_5_13 lung Germany 
55.  65_6_13+7 stomach+liver Germany 
56.  69_13 Russian tortoise 
Testudo horsfieldii 
pharyngeal swab 
 
Flensburg 
Germany 
57.  75_1_13 Hermann’s tortoise 
 Testudo hermanni 
swab   Frankfurt 
Germany 
58.  87_1_13 Tortoises oral swab - 
59.  87_2_13 Tortoise swab - 
60.  87_3_13 Tortoise conjunctiva swab - 
61.  87_4_13 Tortoise oral swab - 
62.  87_5_13 Tortoise oral swab - 
63.  87_6_13 Tortoise cloacal swab - 
64.  87_7_13 Tortoise cloacal swab - 
65.  87_8_13 Tortoise conjunctival 
swab 
- 
66.  87_9_13 Tortoise swab from 
 conj. lid 
- 
67.  89_13 Hermann’s tortoise 
 Testudo hermanni 
swabs from 
 pharynx & eye 
Uni Leipzig 
Germany 
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68.  90_1_13 Indian star tortoise 
Geochelone elegans 
nasal swab Holzhausen 
Germany 
69.  90_2_13 Indian star tortoise 
Geochelone elegans 
nasal swab Holzhausen 
Germany 
70.  91_13 Hermann’s tortoise 
 Testudo hermanni 
swab - 
71.  97_13 Galapagos giant tortoise  
Geochelone nigra 
lung–tongue in 
 paraffin slice  
Uni Zürich 
Switzerland  
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16_04
17_04
5-03, 16-03, 26-
03, 2_4_04, 
5_04, 19_1_04, 
19_2_04,130_12
, 36_13, 62_13
ID 86.3 87.3 87.6 86 86 85.7 86.6 100 86.3 86.3 86.6 87.6 85 40.7 45.9 49.3 38.5
31_03 77.8 ID 91.8 91.2 90.2 99 98.7 89.6 86.3 89.2 99.3 99.6 88.6 79.2 42.2 43.8 49.3 40.7
14_04 78.4 83.1 ID 92.8 96.4 91.5 91.2 93.1 87.3 92.8 91.8 92.2 87 80.8 41.6 43.2 49.3 40.1
15_04 78.6 82.1 83.8 ID 93.1 90.9 90.5 93.8 87.6 93.5 91.2 91.5 87.9 81.4 42.9 44.4 48.4 39.1
16_04
17_04
9_05 75.9 98 81.1 81.1 81.3 ID 98.3 89.2 86 88.9 99 99.3 88.3 78.8 42.2 43.8 49 41
25_09 75 98.7 80.1 79.2 79.4 95 ID 88.9 85.7 88.6 98.7 99 88.6 79.5 42.9 44.7 50 40.7
19_10 79.4 79.4 84.8 86.8 83.1 78.4 76.4 ID 86.6 99 89.6 89.9 86 81.8 42.5 43.5 49.3 40.1
124_(1,2,4
,5,6,7) _10
100 77.8 78.4 78.6 78.6 75.9 75 79.4 ID 86.3 86.3 86.6 87.6 85 40.7 45.9 49.3 38.5
36_10 78.4 78.4 83.8 85.8 82.1 77.4 75.4 98.4 78.4 ID 89.2 89.6 85.7 81.1 42.2 43.2 50 39.5
144_10 77.8 100 83.1 82.1 82.3 98 97 79.4 77.8 78.4 ID 99.6 88.6 79.2 41.9 43.5 49 40.1
659/00 77.8 100 83.1 82.1 82.3 98 97 79.4 77.8 78.4 100 ID 88.9 79.5 42.2 43.8 49.3 40.4
2041/00 74.7 79.4 74.5 73.5 76.4 78.4 78.4 70.8 74.7 69.9 79.4 79.4 ID 83.1 41 45.6 49.3 38.5
TGT1a/96 71.5 62.8 62.1 65.3 62.5 61.9 62.8 66.9 71.5 66 62.8 62.8 67.3 ID 39.5 42.9 50.9 38.8
HEV     16 19.6 16.9 16 16.9 19.6 20.5 16.9 16 16.9 19.6 19.6 16.8 16.8 ID 73.2 58.5 57.3
HCV-A13 15.8 16.6 14.9 15.8 14.9 17.5 18.5 14.9 15.8 14 16.6 16.6 18.5 15.8 54.8 ID 60.8 64
CanPV   18.8 20.7 21.6 19.8 21.6 20.7 19.8 22.4 18.8 21.4 20.7 20.7 19.8 19.4 32 35.8 ID 58.5
HRV-C 16.8 16.9 17.9 15 17.9 17.9 17.9 15.8 16.8 14.9 16.9 16.9 17.1 17.5 36.1 40.3 40.3 ID
9_055-03, 16-03, 26-
03, 2_4_04, 
5_04, 19_1_04, 
19_2_04,130_12
, 36_13, 62_13
31_03 14_04 15_04 25_09 19_10 36_10 144_10 659/00
78.6 82.3 95 86 ID 90.2 89.6 92.2 86 91.8
124_(1,2,4
,5,6,7) _10
40.190.5 87.9 79.5 40.7 42.5 49.390.2
TGT1a/96 HEV     HCV-A13 CanPV HRV-C2041/00
ta 
 
Table 11.3 Identity values (%) of the detected picornaviruses with four members of the family Picornaviridae.  
5_03 group includes isolates 5-03, 16-03, 26-03, 2_4_04, 5_04, 19_1_04, 19_2_04, and samples 130_12, 
36_13, 62_13. The upper diagonal refers to the values for 308 nucleotides. The lower diagonal shows values for 
106 deduced amino acids of the detected viruses. 
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Figure 11.1 Nucleotide alignments (308 nt) of partial polyprotien gene of the detected picornaviruses in 
tortoises. The 5_03 group includes isolates 5-03, 16-03, 26-03, 2_4_04, 5_04, 19_1_04, 19_2_04, and 
samples 130_12, 36_13, 62_13. 
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Species  Samples IBD status 
 
RT-PCR  clinical signs 
remarks 
Origin  Lab no. 
1.  Reticulated python 
Malayopython 
 reticulatus 
kidney 
brain 
pancreas 
intestine 
lung  
n.a. neg. 
brain: pos. 
neg. 
neg. 
neg. 
- Leipzig 15_12 
2.  Reticulated python 
Malayopython 
 reticulatus 
brain  n.a. pos. Male U.K 23_1_12 
3.  Ball pythons  
Python regius 
brain 
kidney 
lung 
liver 
feces 
IBD: neg. 
 
brain:pos. 
neg. 
neg. 
neg. 
neg. 
Encephalitis Germany 47_12 
4.  Indian python 
Python molurus 
kidney 
liver 
lung 
spleen 
n.a. neg. 
neg. 
neg. 
neg. 
- Leipzig  79_12 
Table 11.4  Arenavirus positive results from diagnostic samples during the study period 2012-2013. 
All PCR positives were sequenced.   n.a= not available 
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brain brain:pos. 
5.  Boa 
Boa constrictor 
lung 
kidney 
liver  
intestine 
n.a. pos. 
pos. 
pos. 
pos. 
- Leipzig  128_12 
6.  Boa 
Boa constrictor 
blood IBD neg. pos. - Dr.Michling 
Germany 
134_12: 195A 
7.  Boa 
Boa constrictor 
blood IBD neg. pos. - Dr.Michling 
Germany 
134_12: 196A 
8.  Boa 
Boa constrictor 
blood IBD neg. pos. - Dr.Michling 
Germany 
134_12: 198A 
9.  Boa 
Boa constrictor 
blood IBD neg. pos. - Dr.Michling 
Germany 
134_12: 199A 
10.  Boa 
Boa constrictor 
blood IBD ? pos. - Dr.Michling 
Germany 
134_12: 203A 
11.  Boa 
Boa constrictor 
blood IBD neg. pos. - Dr.Michling 
Germany 
134_12: 206A 
12.  Boa , Albino 
Boa constrictor 
pharyngeal swab  
cloacal swab 
n.a. pos. 
neg. 
- Germany  1_13 
13.  Boa 
Boa constrictor 
pharyngeal swab  n.a. pos. pneumonia Germany  3_13 
14.  Boa pharyngeal swab IBD: neg. pos. - Wilhelma 11_1_13 
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Boa constrictor blood  neg. Germany  
15.  Boa 
Boa constrictor 
pharyngeal swab 
blood 
seven boas 
were housed 
together. Six 
of them were 
reported IBD 
pos.  
pos. 
pos. 
- Wilhelma 
Germany 
11_11_13 
16.  Boa 
Boa constrictor 
pharyngeal swab 
blood 
pos. 
neg. 
- Wilhelma 
Germany 
11_12_13 
17.  Boa 
Boa constrictor 
pharyngeal swab 
blood 
pos. 
pos. 
- Wilhelma 
Germany 
11_13_13 
18.  Boa 
Boa constrictor 
pharyngeal swab 
blood 
pos. 
pos. 
- Wilhelma 
Germany 
11_14_13 
19.  Boa 
Boa constrictor 
pharyngeal swab 
blood 
pos. 
pos. 
- Wilhelma 
Germany 
11_16_13 
20.  Green tree python 
Morelia viridis 
pharyngeal swab 
blood 
IBD: neg. pos. 
neg. 
- Wilhelma 
Germany 
11_22_13 
21.  Boa 
Boa constrictor 
pharyngeal swab 
blood 
IBD: neg. pos. 
pos. 
- Wilhelma 
Germany 
11_25_13 
22.  Boa 
Boa constrictor 
pancreas 
kidney 
intestine 
liver 
lung 
spleen 
IBD: pos pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
- Laboklin  
Germany  
14_1_13 
23.  Boa pancreas IBD: pos pos. - Laboklin  14_2_13 
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Boa constrictor kidney 
intestine 
liver 
lung 
pos. 
pos. 
pos. 
pos. 
Germany  
24.  Boa 
Boa constrictor 
pancreas 
kidney 
intestine 
liver 
lung 
skin  
IBD: pos neg. 
neg. 
neg. 
neg. 
pos. 
pos. 
- Laboklin  
Germany  
14_3_13 
25.  Reticulated python 
Malayopython 
reticulatus 
kidney 
liver 
lung 
intestine  
pancreas 
skin 
brain  
IBD: neg. neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
brain:pos. 
- Laboklin  
Germany 
14_5_13 
26.  Boa 
Boa constrictor 
liver 
trachea 
kidney 
spleen 
lung 
IBD: pos. pos. 
pos. 
pos. 
pos. 
pos. 
- Laboklin 
Germany  
14_7_13 
117 
 
intestine  neg. 
27.  Boa 
Boa constrictor 
lung 
heart 
liver 
kidney 
intestine 
pancreas 
brain  
IBD: neg. pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
inappetence Wilhelma  27_13 
28.  Boa 
Boa constrictor 
swab n.a. pos. - Labnoklin 
Germany  
30_13 
29.  Boa 
Boa constrictor 
pharyngeal swab 
cloacal swab 
n.a. pos. 
pos. 
- Germany  32_13 
30.  Boa 
Boa constrictor 
swab 
blood  
n.a. neg. 
pos. 
 Laboklin  
Germany  
39_13 
31.  Boa 
Boa constrictor 
pharyngeal swab 
blood 
IBD in 
collection 
pos. 
neg. 
- Germany  43_2_13 
32.  Boa 
Boa constrictor 
pharyngeal swab 
blood 
pos. 
pos. 
-  43_6_13 
33.  Boa 
Boa constrictor 
swab  Individual 
inclusions in 
blood smear 
were 
pos. -  44_13 
118 
 
observed 
34.  Indian python 
Python molurus 
pharyngeal swab 
cloacal swab 
skin swab 
n.a pos. 
pos. 
pos. 
Skin problems Leipzig  
Germany 
49_13 
35.  Python  lung lavage n.a pos. Respiratory 
symptoms 
Germany  55_13 
36.  Boa 
Boa constrictor 
blood  n.a pos.  U.K. 94_2_13 
37.  Boa 
Boa constrictor 
serum  
swab  
n.a pos. 
pos. 
- Laboklin 
U.K. 
98_13 
38.  Boa 
Boa constrictor 
spleen 
intestine 
brain 
pharynx 
kidney 
liver 
? 
? 
skin 
IBD: pos. neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
pos. 
neg. 
pos. 
- Laboklin 
Germany 
116_13 
39.  Python  liver 
pancreas 
kidney 
IBD: neg. pos. 
pos. 
pos. 
- Laboklin 
Germany  
117_13 
119 
 
skin 
brain 
gut  
pos. 
pos. 
pos. 
40.  Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
gut 
skin  
IBD: neg. brain:pos. 
neg. 
neg. 
neg. 
neg. 
neg. 
- Laboklin 
Germany 
121_13 
41.  Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
gut 
skin  
lung  
IBD: pos. pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
- Laboklin 
Germany 
122_13 
42.  Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
gut 
skin  
IBD: pos. pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
 Laboklin 
Germany 
123_13 
120 
 
lung  
liver  
pos. 
pos. 
43.  Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
gut 
skin  
lung  
liver  
IBD: pos. pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
- Laboklin 
Germany 
124_13 
44.  Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
gut 
skin  
lung 
liver  
IBD: pos. pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
 Laboklin 
Germany 
125_13 
45.  Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
IBD: pos. pos. 
pos. 
pos. 
pos. 
- Laboklin 
Germany 
126_13 
121 
 
gut 
skin  
liver 
lung  
pos. 
pos. 
pos. 
pos. 
46.  Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
gut 
skin  
lung 
liver  
IBD: neg. brain: pos. 
neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
 Laboklin 
Germany 
127_13 
47.  Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
gut 
skin  
IBD: neg. brain:pos. 
neg. 
neg. 
neg. 
neg. 
neg. 
- Laboklin 
Germany 
128_13 
48.  Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
IBD: pos. pos. 
pos. 
pos. 
pos. 
- Laboklin 
Germany 
129_13 
122 
 
gut 
skin  
lung  
liver  
pos. 
pos. 
pos. 
pos. 
49.  Boa 
Boa constrictor 
CNS 
kidney 
spleen 
gut 
skin  
lung  
liver 
pancreas 
IBD: neg. CNS: pos. 
neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
- Laboklin 
Germany 
131_13 
123 
 
Table 11.5  All samples tested for reptarenaviruses during the study period 2012-1013. 
 
 
Species  Tissue 
samples 
IBD status 
 
RT-PCR 
Reptarenavirus 
Origin Clinical signs, 
Remarks 
Lab no. 
1.  Reticulated python 
Malayopython 
reticulatus 
trachea n.a. neg. U.K n.a. 3_12 
2.  reticulated python 
Malayopython 
reticulatus 
kidney 
brain 
pancreas 
intestine 
lung 
n.a. neg. 
brain: pos. 
neg. 
neg. 
neg. 
Leipzig 
Germany 
n.a. 15_12 
3.  Boa  
Boa constictor 
n.a. n.a. neg. n.a. Male 19_12 
4.  Boa  
Boa constrictor 
n.a. n.a. neg.  n.a. Female 19_5_12 
5.  Reticulated python 
Malayopython 
reticulatus 
brain n.a. pos. U.K Male 23_1_12 
6.  Boa 
Boa contrictor 
brain n.a. neg. U.K Female 23_2_12 
7.  Green tree python pharyngeal n.a. neg. Leipzig Inappetence 24_12 
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Morelia viridis swab 
cloacal 
swab 
tracheal 
flushing 
water 
 
neg. 
neg. 
Germany 
8.  Indian python 
Python molurus 
pancreas 
lung 
kidney 
intestine 
n.a. neg. 
neg. 
neg. 
neg. 
Leipzig 
Germany 
n.a. 25_12 
9.  Python  lung 
liver 
kidney 
intestine 
n.a. neg. 
neg. 
neg. 
neg. 
n.a.  32_12 
10.  Ball python 
Python regius 
brain 
kidney 
lung 
liver 
feces 
IBD: neg. 
 
brain: pos. 
neg. 
neg. 
neg. 
neg. 
cuva Germany Encephalitis 47_12 
11.  Ball python 
Python regius 
fecal 
sample 
n.a. neg. n.a.  50_12 
12.  Indian python pharyngeal IBD in  neg. n.a.  51_12 
125 
 
Python molurus swab 
cloacal 
swab 
collection  
neg. 
13.  Indian python 
Python molurus 
pharyngeal 
swab 
n.a. neg. Leipzig 
Germany 
 52_12 
14.  Ball python 
Python regius 
pharyngeal 
swab 
cloacal 
swab 
n.a. neg. 
 
neg. 
n.a.  53_12 
15.  Indian python 
Python molurus 
kidney 
liver 
lung 
spleen 
brain 
n.a. neg. 
neg. 
neg. 
neg. 
brain: pos. 
Leipzig 
Germany 
 79_12 
16.  Ball python 
Python regius 
lung lavage 
tracheal 
pharyngeal 
flushing 
water 
n.a. neg. 
neg. 
 
n.a.  81_12 
17.  Ball python 
Python regius 
pharyngeal 
swab 
n.a. neg. Leipzig 
Germany 
 97_12 
18.  Ball python pharyngeal n.a. neg. Leipzig  98_12 
126 
 
Python regius swab Germany 
19.  Indian python 
Python molurus 
oral and 
cloacal 
swab 
n.a. neg. Reptilienauffangst 
München 
n.a. 102_12 
20.  Indian python 
Python molurus 
oral and 
cloacal 
swab 
n.a. neg. Reptilienauffangst 
München 
n.a. 102_12 
21.  Indian python 
 Python molurus 
oral and 
cloacal 
swab 
n.a. neg. Reptilienauffangst 
München 
n.a. 102_12 
22.  Reticulated python 
Malayopython 
reticulatus 
oral and 
cloacal 
swab 
n.a. neg. Reptilienauffangst 
München 
n.a. 102_12 
23.  Indian python 
Python molurus 
oral and 
cloacal 
swab 
n.a. neg. Reptilienauffangst 
München 
n.a. 102_12 
24.  Indian python 
Python molurus 
oral and 
cloacal 
swab 
n.a. neg. Reptilienauffangst 
München 
n.a. 102_12 
25.  Indian python 
Python molurus 
oral and 
 cloacal 
swab 
n.a. neg. Reptilienauffangst 
München 
n.a. 102_12 
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26.  Indian python 
Python molurus 
oral and 
cloacal 
swab 
n.a. neg. Reptilienauffangst 
München 
n.a. 102_12 
27.  Indian python 
 Python molurus 
oral and 
 cloacal 
swab 
n.a. neg. Reptilienauffangst 
München 
n.a. 102_12 
28.  Reticulated python 
Malayopython 
reticulatus) 
oral and 
cloacal 
swab 
n.a. neg. Reptilienauffangst 
München 
n.a. 102_12 
29.  Anaconda 
Eunectes murinus 
oral and 
cloacal 
swab 
n.a. neg. Reptilienauffangst 
München 
anorexia 102_12 
30.  Anaconda 
Eunectes murinus 
oral and 
cloacal 
swab 
n.a. neg. Reptilienauffangst 
München 
 102_12 
31.  Anaconda 
Eunectes murinus 
oral and 
cloacal 
swab 
n.a. neg. Reptilienauffangst 
München 
 102_12 
32.  Anaconda 
Eunectes murinus 
oral and 
cloacal 
swab 
n.a. neg. Reptilienauffangst 
München 
 102_12 
33.  Indian python oral and n.a. neg. Reptilienauffangst  102_12 
128 
 
Python molurus) 
 Albino  
cloacal 
swab 
München 
34.  Indian python 
 Python molurus 
 Albino  
oral and 
cloacal 
swab 
n.a. neg. Reptilienauffangst 
München 
 102_12 
35.  Carpet python 
Morelia spilota 
oral swab 
and tracheal 
wash 
n.a. neg. Leipzig 
Germany 
 110_12 
36.  Indian python 
 Python molurus 
intestine 
kidney 
liver 
lung 
n.a. neg. 
neg. 
neg. 
neg. 
Leipzig 
Germany 
 115_12 
37.  Ball python 
Python regius 
intestine 
kidney 
liver 
pancreas 
lung 
brain 
n.a. neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
Leipzig 
Germany 
 115_12 
38.  Green tree python 
Morelia viridis 
lung 
kidney 
intestine 
n.a. neg. 
neg. 
neg. 
Leipzig 
Germany 
 115_12 
39.  Boa  lung n.a. pos. Leipzig  128_12 
129 
 
Boa constrictor kidney 
liver 
intestine 
pos. 
pos. 
pos. 
Germany 
40.  Ball python 
Python regius 
brain 
pancreas 
lung 
kidney 
intestine 
n.a. neg. 
neg. 
neg. 
neg. 
neg. 
Leipzig 
Germany 
 132_12 
41.  Boa 
Boa constrictor 
blood IBD: neg. pos. Deutschland, 
Michling 
 134_12: 
195A 
42.  Boa 
Boa constrictor 
blood IBD: neg. pos. Deutschland, 
Michling 
 134_12: 
196A 
43.  Boa  
Boa constrictor 
blood IBD: neg. pos. Deutschland, 
Michling 
 134_12: 
198A 
44.  Boa  
Boa constrictor 
blood IBD: neg. pos. Deutschland, 
Michling 
 134_12: 
199A 
45.  Boa  
Boa constrictor 
blood IBD ? neg. Deutschland, 
Michling 
 134_12: 
202A 
46.  Boa  
Boa constrictor 
blood IBD ? pos. Deutschland, 
Michling 
 134_12: 
203A 
47.  Boa  
Boa constrictor 
blood IBD: neg. neg. Deutschland, 
Michling 
 134_12: 
204A 
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48.  Boa  
Boa constrictor 
blood IBD: neg. neg. Deutschland, 
Michling 
 134_12: 
205A 
49.  Boa  
Boa constrictor 
blood IBD: neg. pos. Deutschland, 
Michling 
 134_12: 
206A 
50.  Boa  
Boa constrictor 
blood IBD: neg. neg. Deutschland, 
Michling 
 134_12: 
207A 
51.  Boa  
Boa constrictor 
blood IBD: neg. neg. Deutschland, 
Michling 
 134_12: 
208A 
52.  Boa  
Boa constrictor 
blood IBD: neg. neg. Deutschland, 
Michling 
 134_12: 
209A 
53.  Ball python 
Python regius 
lunge 
liver 
brain 
intestine 
n.a. neg. 
neg. 
neg. 
neg. 
Anke Sunshine + 137_12 
54.  Boa  
Boa constrictor 
 Albino 
pharyngeal 
swab 
cloacal 
swab 
n.a. pos. 
 
neg. 
Germany  1_13 
55.  Ball python 
Python regius 
pharyngeal 
swab 
cloacal 
swab 
n.a. neg. 
 
neg. 
n.a. Inappetence, 
CNS symptoms 
2_13 
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56.  Boa  
Boa constrictor 
pharyngeal 
swab 
n.a. pos. Germany Pneumonia 3_13 
57.  Ball python 
Python regius 
kidney 
liver 
lung 
intestine 
IBD: neg. neg. 
neg. 
neg. 
neg. 
Germany (via 
Silvia Blahak) 
Suspected to be 
 infected with 
 Sunshine virus 
8_13 
58.  Ball python 
Python regius 
lung 
leavage 
n.a. neg. n.a. Pneumonia 9_13 
59.  Boa 
Boa constrictor 
pharyngeal 
swab 
blood 
IBD: neg. pos. 
 
neg. 
Wilhelma 
Germany 
 11_1_13 
60.  Indian python 
Python molurus 
pharyngeal 
swab 
blood 
IBD: neg. neg. 
 
neg.  
Wilhelma 
Germany 
 11_2_13 
61.  Rainbow boa 
Epicrates cenchria 
pharyngeal 
swab 
blood 
IBD: neg. neg. 
 
neg. 
Wilhelma 
Germany 
 11_3_13 
62.  Rainbow boa 
Epicrates cenchria 
pharyngeal 
swab 
blood 
IBD: neg. neg. 
 
neg. 
Wilhelma 
Germany 
 11_4_13 
63.  Rainbow boa 
Epicrates cenchria 
pharyngeal 
swab 
IBD: neg. neg. 
 
Wilhelma 
Germany 
 11_5_13 
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blood neg. 
64.  Rainbow boa 
Epicrates cenchria 
pharyngeal 
swab 
blood 
IBD:? neg. 
 
neg. 
Wilhelma 
Germany 
 11_6_13 
65.  Green tree python 
Morelia viridis 
pharyngeal 
swab 
blood 
IBD: neg. neg. 
 
neg. 
Wilhelma 
Germany 
 11_7_13 
66.  Green tree python 
Morelia viridis 
Pharyngeal 
swab 
blood 
IBD: neg. neg. 
 
neg. 
Wilhelma 
Germany 
 11_8_13 
67.  Boa 
Boa constrictor 
pharyngeal 
swab 
blood 
IBD: neg. neg. 
 
neg. 
Wilhelma 
Germany 
 11_9_13 
68.  Boa 
Boa constrictor 
pharyngeal 
swab 
blood 
Seven 
boas were 
housed 
together. 
Six of them 
were 
reported 
IBD pos.  
neg. 
 
neg. 
Wilhelma 
Germany 
 11_10_13 
69.  Boa 
Boa constrictor 
pharyngeal 
swab 
blood 
pos. 
 
pos. 
Wilhelma 
Germany 
 11_11_13 
70.  Boa 
Boa constrictor 
pharyngeal 
swab 
blood 
pos. 
 
neg. 
Wilhelma 
Germany 
 11_12_13 
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71.  Boa 
Boa constrictor 
pharyngeal 
swab 
blood 
pos. 
 
pos. 
Wilhelma 
Germany 
 11_13_13 
72.  Boa 
Boa constrictor 
pharyngeal 
swab 
blood 
pos. 
 
pos. 
Wilhelma 
Germany 
 11_14_13 
73.  Boa 
Boa constrictor 
pharyngeal 
swab 
blood 
neg. 
 
neg. 
Wilhelma 
Germany 
 11_15_13 
74.  Boa 
Boa constrictor 
pharyngeal 
swab 
blood 
pos. 
 
pos. 
Wilhelma 
Germany 
 11_16_13 
75.  Garden tree boa 
Corallus hortulanus 
pharyngeal 
swab 
blood 
n.a. neg. 
 
neg. 
Wilhelma 
Germany 
 11_17_13 
76.  Garden tree boa 
Corallus hortulanus 
pharyngeal 
swab 
blood 
n.a. neg. 
 
neg. 
Wilhelma 
Germany 
 11_18_13 
77.  Garden tree boa 
Corallus hortulanus 
pharyngeal 
swab 
blood 
n.a. neg. 
 
neg. 
Wilhelma 
Germany 
 11_19_13 
78.  Ball python pharyngeal n.a. neg. Wilhelma  11_20_13 
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Python regius swab 
blood 
 
neg. 
Germany 
79.  Ball python 
Python regius 
pharyngeal 
swab 
blood 
IBD: neg. neg. 
 
neg. 
Wilhelma 
Germany 
 11_21_13 
80.  Green tree python 
Morelia viridis 
pharyngeal 
swab 
blood 
IBD: neg. neg. 
 
neg. 
Wilhelma 
Germany 
 11_22_13 
81.  Green tree python 
Morelia viridis 
pharyngeal 
swab 
blood 
IBD: neg. pos. 
 
neg. 
Wilhelma 
Germany 
 11_22_13 
82.  Boa 
Boa constrictor 
pharyngeal 
swab 
blood 
IBD: pos neg. 
 
neg. 
Wilhelma 
Germany 
 11_24_13 
83.  Boa 
Boa constrictor 
pharyngeal 
swab 
blood 
IBD: neg. pos. 
 
pos. 
Wilhelma 
Germany 
 11_25_13 
84.  Indian python 
Python molurus 
pharyngeal 
swab 
blood 
IBD: neg. neg. 
 
neg. 
Wilhelma 
Germany 
 11_26_13 
85.  Boa 
Boa constrictor 
liver 
kidney 
IBD neg. neg. 
neg. 
n.a  13_13 
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lung 
brain 
intestine 
heart 
neg. 
neg. 
neg. 
neg. 
86.  Boa 
Boa constrictor 
pancreas 
kidney 
intestine 
liver 
lung 
spleen 
IBD: pos pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
Laboklin 
Germany 
 14_1_13 
87.  Boa 
Boa constrictor 
pancreas 
kidney 
intestine 
liver 
lung 
IBD: pos pos. 
pos. 
pos. 
pos. 
pos. 
Laboklin 
Germany 
 14_2_13 
88.  Boa 
Boa constrictor 
pancreas 
kidney 
intestine 
liver 
lung 
skin 
IBD: pos neg. 
neg. 
neg. 
neg. 
pos. 
pos. 
Laboklin 
Germany 
 14_3_13 
89.  Ball python brain IBD: neg. neg. Laboklin  14_4_13 
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(Python regius) lung 
liver 
pancreas 
kidney 
intestine 
neg. 
neg. 
neg. 
neg. 
neg. 
Germany 
90.  Reticulated python 
Malayopython 
reticulatus) 
kidney 
liver 
lung 
intestine 
pancreas 
skin 
brain 
IBD: neg. neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
brain: pos. 
Laboklin 
Germany 
 14_5_13 
91.  Ball python 
Python regius 
liver 
kidney 
pancreas 
intestine 
spinal cord 
trachea 
blood 
skin 
pharyngeal 
swab 
IBD: neg. neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
Laboklin 
Germany 
 14_6_13 
137 
 
92.  Boa 
Boa constrictor 
liver 
trachea 
kidney 
spleen 
lung 
intestine 
IBD: pos pos. 
pos. 
pos. 
pos. 
pos. 
neg. 
Laboklin 
Germany 
 14_7_13 
93.  Ball python 
Python regius 
liver 
kidney 
pancreas 
intestine 
spinal cord 
trachea 
brain 
skin 
IBD: neg. neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
Laboklin 
Germany 
 14_8_13 
94.  Indian python 
Python molurus 
liver 
kidney 
spinal cord 
IBD: neg. neg. 
neg. 
neg. 
Laboklin 
Germany 
 17_13 
95.  Boa 
Boa constrictor 
oral and 
cloacal 
swab 
n.a. neg. Laboklin 
Germany 
Male 21_13 
96.  Boa 
Boa constrictor 
oral and 
cloacal 
n.a. neg. Laboklin 
Germany 
Female 21_13 
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swab 
97.  Ball python 
Python regius 
brain 
liver 
lung 
kidney 
skin 
n.a. neg. 
neg. 
neg. 
neg. 
neg. 
Laboklin 
Germany 
Rana virus pos. 23_13 
98.  Boa 
Boa constrictor 
lung 
heart 
liver 
kidney 
intestine 
pancreas 
brain 
IBD: neg. pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
Wilhelma 
Germany 
Inappetence 27_13 
99.  Boa 
Boa constrictor 
swab n.a. pos. Labnoklin 
Germany 
 30_13 
100. Boa 
Boa constrictor 
pharyngeal 
swab 
cloacal 
swab 
n.a. pos. 
 
pos. 
Germany  32_13 
101. Boa 
Boa constrictor 
tissue pool n.a. neg. Laboklin 
Germany 
Losing weight 38_1_13 
102. Indian python kidney n.a. neg. Laboklin Skin problems 38_2_13 
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Python molurus brain 
lung 
heart 
pancreas 
neg. 
neg. 
neg. 
neg. 
Germany 
103. Boa 
Boa constrictor 
swab 
blood 
n.a. neg. 
pos. 
Laboklin 
Germany 
 39_13 
104. Boa 
Boa constrictor 
pharyngeal 
swab 
cloacal 
swab 
skin 
n.a. neg. 
 
neg. 
 
neg. 
Laboklin 
Germany 
 40_13 
105. Boa 
Boa constrictor 
pharyngeal 
swab 
blood 
IBD in 
 collection 
neg. 
 
neg. 
Germany  43_1_13 
106. Boa 
Boa constrictor 
pharyngeal 
swab 
blood 
pos. 
 
neg. 
Germany  43_2_13 
107. African rock python 
Python sebae 
pharyngeal 
swab 
blood 
neg. 
 
neg. 
Germany  43_3_13 
108. Indian python 
Python molurus 
pharyngeal 
swab 
neg. 
 
Germany  43_4_13 
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blood neg. 
109. Indian python 
Python molurus 
pharyngeal 
swab 
blood 
neg. 
 
neg. 
Germany  43_5_13 
110. Boa 
Boa constrictor 
pharyngeal 
swab 
blood 
pos. 
 
pos. 
Germany  43_6_13 
111. Indian python 
Python molurus 
pharyngeal 
swab 
blood 
neg. 
 
neg. 
Germany  43_7_13 
112. Indian python 
Python molurus 
pharyngeal 
swab 
blood 
neg. 
 
neg. 
Germany  43_8_13 
113. Ball python 
Python regius 
pharyngeal 
swab 
blood 
neg. 
 
neg. 
Germany  43_9_13 
114. Ball python 
Python regius 
pharyngeal 
swab 
blood 
neg. 
 
neg. 
Germany  43_10_13 
115. Unknown  pharyngeal 
swab 
blood 
neg. 
 
neg. 
Germany  43_11_13 
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116. Madagascar boa 
Arcantophis sp. 
pharyngeal 
swab 
blood 
neg. 
 
neg. 
Germany  43_12_13 
117. Boa 
Boa constrictor 
swab 
blood 
n.a. neg. 
neg. 
Germany  44_13 
118. Rainbow boa 
Epicrates cenchria 
swab n.a. neg. Germany  44_13 
119. Rainbow boa 
Epicrates cenchria 
swab n.a. neg. Germany  44_13 
120. Rainbow boa 
Epicrates cenchria 
swab n.a. neg. Germany  44_13 
121. Green tree python 
Morelia viridis 
swab n.a. neg. Germany  44_13 
122. Indian python 
Python molurus 
swab n.a. neg. Germany  44_13 
123. Garden tree boa 
Corallus hortulanus 
swab n.a. neg. Germany  44_13 
124. Garden tree boa 
Corallus hortulanus 
swab n.a. neg. Germany  44_13 
125. Ball python 
Python regius 
swab n.a. neg. Germany  44_13 
126. Ball python swab n.a. neg. Germany  44_13 
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Python regius blood neg. 
127. Green tree python 
Morelia viridis 
swab n.a. neg. Germany  44_13 
128. Green tree python 
Morelia viridis 
swab n.a. neg. Germany  44_13 
129. Boa 
Boa constrictor 
swab Individual 
inclusions 
in blood 
smear were 
observed 
pos. Germany  44_13 
130. Indian python 
Python molurus 
swab n.a. neg. Germany  44_13 
131. Indian python 
Python molurus 
swab 
blood 
n.a. neg. 
neg. 
Germany  44_13 
132. Indian python 
Python molurus 
 albino 
swab 
blood 
n.a. neg. 
neg. 
Germany  44_13 
133. Boa 
Boa constrictor 
pharyngeal 
swab 
cloacal 
swab 
n.a. neg. 
 
neg. 
Germany  46_13 
134. Indian python pharyngeal n.a pos. Germany skin problems 49_13 
143 
 
Python molurus swab 
cloacal 
swab 
skin swab 
 
pos. 
pos. 
135. Python  lung lavage n.a pos. Germany respiratory 
symptoms 
55_13 
136. Rosy boa 
Lichanura trivirgata 
swab n.a neg. Germany  56_13 
137. Boa constrictor swab 
blood 
n.a. neg. 
neg. 
Germany  57_13 
138. Boa constrictor swab 
blood 
IBD: pos.  neg. 
neg. 
Germany Stomatitis, 
dermatitis 
58_13 
139. Green tree python 
Morelia viridis 
brain 
lung 
intestine 
kidney 
swab 
blood 
n.a neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
Leipzig 
Germany 
 60_13 
140. Rainbow boa 
Epicrates cenchria 
swabs n.a neg. Laboklin 
Germany 
 63_13 
141. Boa swab n.a neg. Laboklin, UK  70_2_13 
144 
 
Boa constrictor 
142. Boa 
Boa constrictor 
swab n.a. neg.  Laboklin, UK  70_3_13 
143. Ball python 
Python regius 
swab n.a neg. Laboklin, UK  73_13 
144. Boa 
Boa constrictor 
swab 
blood 
n.a neg. 
neg. 
Laboklin, UK  80_13 
145. Green tree python 
Morelia viridis 
swab 
blood 
n.a neg. 
neg. 
Laboklin, UK  80_13 
146. Boa 
Boa constrictor 
RNA n.a neg. Laboklin, UK  86_13 
147. Boa  
Boa constrictor 
swab 
blood 
n.a neg. 
neg. 
Laboklin, UK  92_13 
148. Carpet python 
Morelia spilota 
swab n.a neg. U.K.  94_1_13 
149. Boa 
Boa constrictor 
blood n.a pos. U.K.  94_2_13 
150. Boa 
Boa constrictor 
blood n.a. neg. UK  94_3_13 
151. Boa  
Boa constrictor 
serum 
swab 
n.a pos. 
pos. 
Laboklin UK  98_13 
152. Ball python tissue pool IBD: neg. neg. Laboklin Germany  115_13 
145 
 
Python regius 
153. Boa 
Boa constrictor 
spleen 
intestine 
brain 
pharynx 
kidney 
liver 
skin 
two 
undefined 
organs 
IBD: pos. neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
pos. 
neg. 
pos. 
Laboklin 
Germany 
 116_13 
154. Python  liver 
pancreas 
kidney 
skin 
brain 
gut 
IBD: neg. pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
Laboklin 
Germany 
PCR and RNA 
 extraction 
repeated 
117_13 
155. Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
gut 
IBD: neg. brain: pos. 
neg. 
neg. 
neg. 
neg. 
Laboklin 
Germany 
 121_13 
146 
 
skin neg. 
156. Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
gut 
skin 
lung 
IBD: pos. pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
Laboklin 
Germany 
 122_13 
157. Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
gut 
skin 
lung 
liver 
IBD: pos. pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
Laboklin 
Germany 
 123_13 
158. Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
gut 
skin 
IBD: pos. pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
Laboklin 
Germany 
 124_13 
147 
 
lung 
liver 
pos. 
pos. 
159. Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
gut 
skin 
lung 
liver 
IBD: pos. pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
Laboklin 
Germany 
 125_13 
160. Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
gut 
skin 
liver 
lung 
IBD: pos. pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
Laboklin 
Germany 
 126_13 
161. Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
IBD: neg. brain: pos. 
neg. 
neg. 
neg. 
Laboklin 
Germany 
 127_13 
148 
 
gut 
skin 
lung 
liver 
neg. 
neg. 
neg. 
neg. 
162. Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
gut 
skin 
IBD: neg. brain: pos. 
neg. 
neg. 
neg. 
neg. 
neg. 
Laboklin 
Germany 
 128_13 
163. Boa 
Boa constrictor 
brain 
pancreas 
kidney 
spleen 
gut 
skin 
lung 
liver 
IBD: pos. pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
pos. 
Laboklin 
Germany 
 129_13 
164. Ball python 
Python regius 
brain 
kidney 
spleen 
gut 
IBD: neg. neg. 
neg. 
neg. 
neg. 
Laboklin 
Germany 
 130_13 
149 
 
skin 
lung 
liver 
pancreas 
neg. 
neg. 
neg. 
neg. 
165. Boa 
Boa constrictor 
CNS 
kidney 
spleen 
gut 
skin 
lung 
liver 
pancreas 
IBD: neg. CNS: pos. 
neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
Laboklin 
Germany 
 131_13 
166. Ball python 
Python regius 
gut 
CNS 
pancreas 
skin 
liver 
kidney 
lung 
testis 
IBD: neg. neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
Laboklin 
Germany 
 132_13 
167.  Ball python 
Python regius 
gut 
CNS 
IBD: neg. neg. 
neg. 
Laboklin 
Germany 
 133_13 
150 
 
pancreas 
skin 
liver 
kidney 
lung 
testis 
neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
168. Ball python 
Python regius 
pharyngeal 
+ 
cloacal 
swab 
n.a. neg.   145_13 
169. Python albino blood n.a. neg. U.K.  156_13 
170. Green tree python 
Morelia viridis 
swab 
lung 
liver 
heart 
intestine 
pancreas 
brain 
IBD: neg. neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
neg. 
Wilhelma 
Germany 
 143_13 and 
158_13 
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Seq-> 15_2_12 23_1_12 79_5_12 134_6_12 134_3_12 1_2_13 3_13 11_1_13R 11_16_13B 11_23_13R 14_1_13ni 14_2_13Da 14_7_13Le 14_3_13lu 27_1_13 32_1_13 39_2_13 43_2_13 43_6_13ra 55_1_13 55_3_13
15_2_12 ID 77.5 100 86.6 77.5 83.9 83.9 94.1 88.7 89.3 83.4 99.4 83.4 79.1 77.5 80.2 76.4 79.1 77.5 78 84.4
23_1_12 93.6 ID 77.5 78 79.6 78 78 77 74.8 74.8 78 77 78.6 78 80.2 80.7 96.2 78 80.2 79.6 79.1
79_5_12 100 93.6 ID 86.6 77.5 83.9 83.9 94.1 88.7 89.3 83.4 99.4 83.4 79.1 77.5 80.2 76.4 79.1 77.5 78 84.4
134_6_12 96.8 93.6 96.8 ID 76.4 83.9 83.9 87.1 84.4 84.4 83.9 86 83.4 75.9 80.2 81.2 78.6 75.9 80.2 80.2 85.5
134_3_12 90.4 92 90.4 90.4 ID 75.9 75.9 78 75.9 75.9 75.9 77.5 75.4 78 75.4 75.9 79.6 78 75.4 74.8 75.9
1_2_13 98.4 93.6 98.4 98.4 88.8 ID 100 83.9 86.6 86.6 99.4 83.4 99.4 76.4 81.2 79.1 78.6 76.4 81.2 81.2 98.3
3_13 98.4 93.6 98.4 98.4 88.8 100 ID 83.9 86.6 86.6 99.4 83.4 99.4 76.4 81.2 79.1 78.6 76.4 81.2 81.2 98.3
11_1_13R 100 93.6 100 96.8 90.4 98.4 98.4 ID 87.1 87.7 83.4 94.6 83.4 78.6 79.1 80.7 75.9 78.6 79.1 79.6 84.4
11_16_13B 98.4 93.6 98.4 98.4 88.8 100 100 98.4 ID 99.4 86 89.3 86 77 79.6 75.9 74.3 77 79.6 80.2 86
11_23_13R 98.4 93.6 98.4 98.4 88.8 100 100 98.4 100 ID 86 89.8 86 77 79.1 76.4 74.3 77 79.1 80.7 86
14_1_13ni 98.4 93.6 98.4 98.4 88.8 100 100 98.4 100 100 ID 82.8 98.9 76.4 80.7 79.1 78.6 76.4 80.7 80.7 97.8
14_2_13Da 100 93.6 100 96.8 90.4 98.4 98.4 100 98.4 98.4 98.4 ID 82.8 79.6 77.5 80.7 75.9 79.6 77.5 78 83.9
14_7_13Le 98.4 93.6 98.4 98.4 88.8 100 100 98.4 100 100 100 98.4 ID 77 80.7 79.6 79.1 77 80.7 80.7 97.8
14_3_13lu 95.2 93.6 95.2 95.2 87.3 95.2 95.2 95.2 95.2 95.2 95.2 95.2 95.2 ID 77 82.8 80.7 99.4 77 77.5 76.4
27_1_13 96.8 95.2 96.8 96.8 88.8 96.8 96.8 96.8 96.8 96.8 96.8 96.8 96.8 98.4 ID 79.6 81.8 77.5 100 98.3 81.2
32_1_13 95.2 96.8 95.2 95.2 90.4 95.2 95.2 95.2 95.2 95.2 95.2 95.2 95.2 98.4 98.4 ID 81.2 82.8 79.6 80.2 79.6
39_2_13 93.6 98.4 93.6 95.2 93.6 93.6 93.6 93.6 93.6 93.6 93.6 93.6 93.6 93.6 95.2 96.8 ID 80.7 81.8 81.2 79.6
43_2_13 95.2 93.6 95.2 95.2 87.3 95.2 95.2 95.2 95.2 95.2 95.2 95.2 95.2 100 98.4 96.8 93.6 ID 77.5 78 76.4
43_6_13ra 96.8 95.2 96.8 96.8 88.8 96.8 96.8 96.8 96.8 96.8 96.8 96.8 96.8 98.4 100 98.4 95.2 98.4 ID 98.3 81.2
55_1_13 96.8 95.2 96.8 96.8 88.8 96.8 96.8 96.8 96.8 96.8 96.8 96.8 96.8 98.4 100 98.4 95.2 98.4 100 ID 81.2
55_3_13 98.4 93.6 98.4 98.4 88.8 100 100 98.4 100 100 100 98.4 100 95.2 96.8 95.2 93.6 95.2 96.8 96.8 ID
55_4_13 85.7 82.5 85.7 87.3 79.3 87.3 87.3 85.7 87.3 87.3 87.3 85.7 87.3 84.1 85.7 84.1 82.5 84.1 85.7 85.7 87.3
56_2_13 98.4 93.6 98.4 98.4 88.8 100 100 98.4 100 100 100 98.4 100 95.2 96.8 95.2 93.6 95.2 96.8 96.8 100
11_25_13b 98.4 93.6 98.4 98.4 88.8 100 100 98.4 100 100 100 98.4 100 95.2 96.8 95.2 93.6 95.2 96.8 96.8 100
44_21_13 92 96.8 92 93.6 92 92 92 92 92 92 92 92 92 92 93.6 95.2 98.4 92 93.6 93.6 92
67_4_13 92 96.8 92 92 90.4 92 92 92 92 92 92 92 92 92 93.6 95.2 96.8 92 93.6 93.6 92
94_2_13 98.4 93.6 98.4 98.4 88.8 100 100 98.4 100 100 100 98.4 100 95.2 96.8 95.2 93.6 95.2 96.8 96.8 100
98_1_13 98.4 93.6 98.4 98.4 88.8 100 100 98.4 100 100 100 98.4 100 95.2 96.8 95.2 93.6 95.2 96.8 96.8 100
94_3_13 98.4 93.6 98.4 98.4 88.8 100 100 98.4 100 100 100 98.4 100 95.2 96.8 95.2 93.6 95.2 96.8 96.8 100
128_7_13 98.4 93.6 98.4 98.4 88.8 100 100 98.4 100 100 100 98.4 100 95.2 96.8 95.2 93.6 95.2 96.8 96.8 100
131_1_13 100 93.6 100 96.8 90.4 98.4 98.4 100 98.4 98.4 98.4 100 98.4 95.2 96.8 95.2 93.6 95.2 96.8 96.8 98.4
168_1_13 96.8 90.4 96.8 93.6 87.3 95.2 95.2 96.8 95.2 95.2 95.2 96.8 95.2 92 93.6 92 90.4 92 93.6 93.6 95.2
116_9_13 96.8 95.2 96.8 96.8 88.8 96.8 96.8 96.8 96.8 96.8 96.8 96.8 96.8 98.4 100 98.4 95.2 98.4 100 100 96.8
126_7_13 96.8 95.2 96.8 96.8 88.8 96.8 96.8 96.8 96.8 96.8 96.8 96.8 96.8 98.4 100 98.4 95.2 98.4 100 100 96.8
168_2_13 96.8 95.2 96.8 98.4 90.4 96.8 96.8 96.8 96.8 96.8 96.8 96.8 96.8 96.8 98.4 98.4 96.8 96.8 98.4 98.4 96.8
122_1_13 96.8 95.2 96.8 96.8 88.8 96.8 96.8 96.8 96.8 96.8 96.8 96.8 96.8 98.4 100 98.4 95.2 98.4 100 100 96.8
121_2_13 92 87.3 92 90.4 85.7 90.4 90.4 92 90.4 90.4 90.4 92 90.4 88.8 90.4 88.8 87.3 88.8 90.4 90.4 90.4
116_7_13 98.4 93.6 98.4 98.4 88.8 100 100 98.4 100 100 100 98.4 100 95.2 96.8 95.2 93.6 95.2 96.8 96.8 100
124_1_13 96.8 92 96.8 96.8 87.3 98.4 98.4 96.8 98.4 98.4 98.4 96.8 98.4 93.6 95.2 93.6 92 93.6 95.2 95.2 98.4
BoaAV NL3 100 93.6 100 96.8 90.4 98.4 98.4 100 98.4 98.4 98.4 100 98.4 95.2 96.8 95.2 93.6 95.2 96.8 96.8 98.4
GGV 96.8 93.6 96.8 100 90.4 98.4 98.4 96.8 98.4 98.4 98.4 96.8 98.4 95.2 96.8 95.2 95.2 95.2 96.8 96.8 98.4
CAS 87.3 84.1 87.3 85.7 79.3 87.3 87.3 87.3 87.3 87.3 87.3 87.3 87.3 87.3 85.7 84.1 84.1 87.3 85.7 85.7 87.3
UHV 92 90.4 92 92 84.1 92 92 92 92 92 92 92 92 93.6 95.2 93.6 90.4 93.6 95.2 95.2 92
Table 11.6 Identity values (%) of the detected reptarenviruses and GGV, Boa AV NL B3,UHV and CASV. The upper 
diagonal refers to the values for 187 nucleotides. The lower diagonal shows values for 62 deduced amino acids of the 
detected viruses. GenBank accession numbers: Golden Gate Virus (JQ717264), Boa Arenavirus Netherlands 
(KC508669), California Academy of Sciences (JQ717262) and University of Helsinki Virus (KF297880). 
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55_4_13 56_2_13 11_25_13b 44_21_13 67_4_13 94_2_13 98_1_13 94_3_13 128_7_13 131_1_13 168_1_13 116_9_13 126_7_13 168_2_13 122_1_13 121_2_13 116_7_13 124_1_13 BoaAV NL3 GGV CAS UHV
79.1 83.4 83.4 79.1 80.2 84.4 82.8 83.9 89.3 99.4 91.9 78 78 78.6 77.5 92.5 83.4 88.7 94.1 86 76.4 78
75.9 77.5 77 90.3 87.7 79.1 77.5 78 74.8 77 76.4 80.2 80.7 80.2 80.2 74.8 77.5 75.4 77 77.5 73.2 78
79.1 83.4 83.4 79.1 80.2 84.4 82.8 83.9 89.3 99.4 91.9 78 78 78.6 77.5 92.5 83.4 88.7 94.1 86 76.4 78
77 83.4 88.2 80.2 78 83.4 88.7 83.9 84.4 86 86 79.6 81.8 80.7 80.2 81.2 84.4 85 87.1 98.3 73.7 77.5
72.7 75.9 75.9 79.6 77.5 75.9 74.3 75.9 75.9 77.5 77.5 75.4 76.4 76.4 75.4 75.9 75.4 75.4 78 75.9 71.1 74.8
79.6 99.4 83.4 80.2 79.6 97.8 82.8 100 86.6 83.4 82.8 80.7 81.8 80.7 81.8 78 99.4 87.1 83.9 83.9 78 75.9
79.6 99.4 83.4 80.2 79.6 97.8 82.8 100 86.6 83.4 82.8 80.7 81.8 80.7 81.8 78 99.4 87.1 83.9 83.9 78 75.9
77.5 84.4 86 78 78 84.4 86.6 83.9 87.7 94.6 97.8 79.6 79.6 80.2 79.1 87.1 83.4 87.1 100 86.6 78.6 76.4
80.2 87.1 82.8 77.5 80.7 86 84.4 86.6 99.4 89.3 85.5 80.2 81.2 79.6 80.2 82.3 86 98.3 87.1 85 76.4 74.8
80.7 87.1 83.4 77.5 80.7 86 85 86.6 100 89.8 85.5 79.6 80.7 79.1 79.6 82.8 86 98.3 87.7 85 75.9 75.4
79.1 98.9 83.4 80.2 79.6 97.3 82.8 99.4 86 82.8 82.3 80.2 81.2 80.2 81.2 77.5 98.9 86.6 83.4 83.9 77.5 75.9
79.1 83.9 83.9 78.6 79.6 83.9 83.4 83.4 89.8 100 92.5 78 78 78.6 77.5 91.9 82.8 89.3 94.6 86.6 75.9 77.5
79.1 98.9 82.8 79.6 79.1 97.3 82.3 99.4 86 82.8 82.3 80.2 81.2 80.2 81.2 77.5 98.9 86.6 83.4 83.4 77.5 75.4
73.7 77 77 78.6 78 77 78.6 76.4 77 79.6 78 76.4 75.9 76.4 77 77 75.9 77 78.6 77 72.7 79.6
86.6 81.2 79.6 80.2 78.6 80.7 80.7 81.2 79.1 77.5 77.5 99.4 98.3 98.3 99.4 75.4 80.7 79.6 79.1 79.6 75.4 75.9
74.3 79.6 80.7 79.6 81.2 78 81.2 79.1 76.4 80.7 79.1 79.1 79.1 79.1 80.2 75.4 79.6 75.9 80.7 82.8 74.3 80.7
77 78 77 93 88.7 79.6 79.1 78.6 74.3 75.9 75.4 81.2 82.3 81.2 82.3 74.3 78 75.4 75.9 79.1 72.1 79.1
74.3 77 77 78.6 78 77 78.6 76.4 77 79.6 78 77 76.4 77 77 77 75.9 77 78.6 77 72.7 79.6
86.6 81.2 79.6 80.2 78.6 80.7 80.7 81.2 79.1 77.5 77.5 99.4 98.3 98.3 99.4 75.4 80.7 79.6 79.1 79.6 75.4 75.9
87.1 81.2 80.2 80.2 79.6 80.7 80.7 81.2 80.7 78 77.5 97.8 97.8 96.7 97.8 75.4 80.7 80.7 79.6 79.6 73.7 77
79.6 97.8 83.9 80.7 80.2 96.2 83.4 98.3 86 83.9 83.4 80.7 81.8 80.7 81.8 78 97.8 86.6 84.4 85.5 77 74.8
ID 79.6 76.4 78 76.4 79.6 77.5 79.6 80.7 79.1 75.4 86 87.1 85.5 86 75.4 79.1 80.7 77.5 77 71.1 71.6
87.3 ID 83.9 79.6 79.1 97.3 83.4 99.4 87.1 83.9 83.4 80.7 81.8 80.7 81.8 77.5 98.9 87.7 84.4 84.4 77.5 75.4
87.3 100 ID 79.1 78 82.8 90.9 83.4 83.4 83.9 83.9 79.1 79.1 80.2 79.6 76.4 82.8 83.4 86 87.7 74.3 79.6
80.9 92 92 ID 94.1 80.2 78.6 80.2 77.5 78.6 76.4 79.6 81.2 79.6 80.7 75.4 79.6 77.5 78 80.7 72.1 78
80.9 92 92 95.2 ID 79.1 77.5 79.6 80.7 79.6 76.4 79.1 80.2 77.5 79.1 75.4 79.1 80.7 78 78.6 71.6 79.1
87.3 100 100 92 92 ID 82.3 97.8 86 83.9 83.4 80.2 81.2 80.2 81.2 78.6 97.3 86.6 84.4 83.4 78.6 75.4
87.3 100 100 92 92 100 ID 82.8 85 83.4 85 80.2 79.6 80.2 81.2 77.5 83.4 85 86.6 89.3 74.3 79.1
87.3 100 100 92 92 100 100 ID 86.6 83.4 82.8 80.7 81.8 80.7 81.8 78 99.4 87.1 83.9 83.9 78 75.9
87.3 100 100 92 92 100 100 100 ID 89.8 85.5 79.6 80.7 79.1 79.6 82.8 86 98.3 87.7 85 75.9 75.4
85.7 98.4 98.4 92 92 98.4 98.4 98.4 98.4 ID 92.5 78 78 78.6 77.5 91.9 82.8 89.3 94.6 86.6 75.9 77.5
82.5 95.2 95.2 88.8 88.8 95.2 95.2 95.2 95.2 96.8 ID 78 78 78.6 77.5 85 82.3 85.5 97.8 85.5 77.5 74.8
85.7 96.8 96.8 93.6 93.6 96.8 96.8 96.8 96.8 96.8 93.6 ID 97.8 98.3 98.9 75.4 80.2 79.6 79.6 79.1 74.8 75.4
85.7 96.8 96.8 93.6 93.6 96.8 96.8 96.8 96.8 96.8 93.6 100 ID 96.7 97.8 75.4 81.2 81.2 79.6 81.2 75.4 75.9
85.7 96.8 96.8 95.2 93.6 96.8 96.8 96.8 96.8 96.8 93.6 98.4 98.4 ID 97.8 76.3 80.2 80.1 80.2 80.2 74.8 74.3
85.7 96.8 96.8 93.6 93.6 96.8 96.8 96.8 96.8 96.8 93.6 100 100 98.4 ID 75.4 81.2 80.2 79.1 80.2 75.4 76.4
82.5 90.4 90.4 87.3 85.7 90.4 90.4 90.4 90.4 92 88.8 90.4 90.4 90.4 90.4 ID 77.5 83.3 87.1 80.7 70.5 75.4
87.3 100 100 92 92 100 100 100 100 98.4 95.2 96.8 96.8 96.8 96.8 90.4 ID 86.6 83.4 84.4 77.5 75.4
85.7 98.4 98.4 90.4 93.6 98.4 98.4 98.4 98.4 96.8 93.6 95.2 95.2 95.2 95.2 88.8 98.4 ID 87.1 85.5 76.4 75.4
85.7 98.4 98.4 92 92 98.4 98.4 98.4 98.4 100 96.8 96.8 96.8 96.8 96.8 92 98.4 96.8 ID 86.6 78.6 76.4
87.3 98.4 98.4 93.6 92 98.4 98.4 98.4 98.4 96.8 93.6 96.8 96.8 98.4 96.8 90.4 98.4 96.8 96.8 ID 72.1 78
74.6 87.3 87.3 82.5 82.5 87.3 87.3 87.3 87.3 87.3 84.1 85.7 85.7 85.7 85.7 79.3 87.3 85.7 87.3 85.7 ID 70
80.9 92 92 88.8 88.8 92 92 92 92 92 88.8 95.2 95.2 93.6 95.2 85.7 92 90.4 92 92 84.1 ID
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Figure 11.2 Nucleotide alignments (187 nt) of partial GP gene of the detected reptarenaviruses and GGV, Boa AV NL3, UHV 
and CAS. Identity shading refers to 80% among arenaviruses. GenBank accession numbers: Golden Gate Virus (GGV 
JQ717264), Boa Arenavirus Netherlands (Boa AV NLB3 KC508669), California Academy of Sciences (CASV JQ717262) and 
University of Helsinki Virus (UHV-1 KF297880). 
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Figure 11.3 Nucleotide alignments (148 nt) of the detected sunshinevirus in snakes in Germany and Reptile 
sunshinevirus 1 Genbank accession number: JN192445  
 
10 20 30 40 50
....|....| ....|....| ....|....| ....|....| ....|....|
81_1,2_12,89_12, Milla,P4,P8 CACTTGGACT CAGTTAAGAG ATTTTTGAAG ACTTTCACTG AGTTTAACAG
16_13H CACTTGGACT CAGTTAAGAG ATTTTTGAAG ACTTTCACTG ATTTTAACAG
Tia CACTTGGACT CAGTTAAGAG ATTTTTGAAG ACTTTCACTG AGTTTAACAG
sunshinevirus CACTTGGACT CAGTTAAGAG ATTTTTGAAG ACTTTCACTG AGTTTAACAG
60 70 80 90 100
....|....| ....|....| ....|....| ....|....| ....|....|
81_1,2_12,89_12, Milla,P4,P8 TGCAATGGGA CATGAATTAA AAGTAGAGGA GACGATAATA TCTAGAGAGA
16_13H TCCACTGGGA CTTGAATTAA AAGTAGAGGA GACGATAGTA TCTAGAGAGA
Tia TGCAATGGGA CATGAGTTAA AAGTAGAGGA GACGATAATA TCTAGAGAGA
sunshinevirus TGCAATGGGA CATGAATTAA AAGTAGAGGA GACGATAATA TCTAGAGAGA
110 120 130 140
....|....| ....|....| ....|....| ....|....| ....|...
81_1,2_12,89_12, Milla,P4,P8 TCTTTGTATA TTCCAAGAAA ATATATAGGA AAGGGAGGTC TATGGGAA
16_13H TCTTTGTATA TTCCAAGAAG CTGTATACGA AAGGGTGGTC TTTCAAGG
Tia TCTTTGTATA TTCCAAGAAA ATATATAGGA AAGGGAGGTC TATGGGAA
sunshinevirus TCTTTGTATA TTCCAAGAAA ATATATAGGA AAGGGAGGTC TATGGGAA
Reptile su shinevirus 1 
Reptile su shinevirus 1 
Reptile sunshinevirus 1 
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